WO2014003416A1 - Polymerizable liquid crystal compound, and liquid crystal composition and optically anisotropic body comprising same - Google Patents

Polymerizable liquid crystal compound, and liquid crystal composition and optically anisotropic body comprising same Download PDF

Info

Publication number
WO2014003416A1
WO2014003416A1 PCT/KR2013/005608 KR2013005608W WO2014003416A1 WO 2014003416 A1 WO2014003416 A1 WO 2014003416A1 KR 2013005608 W KR2013005608 W KR 2013005608W WO 2014003416 A1 WO2014003416 A1 WO 2014003416A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
liquid crystal
group
polymerizable liquid
crystal compound
Prior art date
Application number
PCT/KR2013/005608
Other languages
French (fr)
Korean (ko)
Inventor
서경창
전성호
최대승
홍미라
장형빈
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Priority to CN201380028069.9A priority Critical patent/CN104379699B/en
Priority to JP2015520011A priority patent/JP6042538B2/en
Priority to US14/355,898 priority patent/US9127104B2/en
Priority claimed from KR1020130072986A external-priority patent/KR101502488B1/en
Publication of WO2014003416A1 publication Critical patent/WO2014003416A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/22Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and nitrogen atoms as chain links, e.g. Schiff bases
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • C09K19/322Compounds containing a naphthalene ring or a completely or partially hydrogenated naphthalene ring
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • G02B5/3016Polarising elements involving passive liquid crystal elements
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • C09K2019/2078Ph-COO-Ph-COO-Ph

Definitions

  • the present invention relates to a polymerizable liquid crystal compound, a liquid crystal composition comprising the same and an optically anisotropic body.
  • a phase retarder is a type of optical device that changes the polarization state of light passing through it, also called a wave plate.
  • the polarization direction field vector direction
  • the polarization direction is the sum of two components (normal and extraordinary) parallel or perpendicular to the optical axis, and the vector sum of the two components depends on the birefringence and thickness of the phase retarder. Since it changes, the polarization direction after passing is different.
  • the present invention is to provide a polymerizable liquid crystal compound having high birefringence and excellent in orientation during coating.
  • this invention is providing the polymerizable liquid crystal composition containing the said compound.
  • this invention is providing the optically anisotropic body containing the polymer of the said polymeric liquid crystal composition.
  • a polymerizable liquid crystal compound 0 represented by Formula 1 is provided:
  • A is an alkyl group having 1 to 10 carbon atoms
  • D 1 , D 2 , G 1 and G 2 are each independently a single bond or a divalent linking group, wherein at least one of D 1 , D 2 , G 1 and G 2 is an imine group;
  • E 1 and E 2 are each independently a benzene ring or a naphthalene ring, and at least one of E 1 and E 2 is a naphthalene ring;
  • J 1 and J 2 are each independently an alkylene group of 1 to 10 carbohydrates
  • L 1 and L 2 are each independently hydrogen or a polymerizable group.
  • a polymerizable liquid crystal composition including the compound represented by Chemical Formula 1 is provided.
  • an optically anisotropic body including a cured product or a polymer of the polymerizable liquid crystal compound is provided.
  • the polymerizable liquid crystal compound according to the present invention not only has a high birefringence but also has excellent orientation in coating, thereby enabling the production of an optically anisotropic body having a thin thickness and excellent optical properties.
  • the 'polymerizable liquid crystal compound' is a liquid crystal compound having a polymerizable functional group, and after aligning a liquid crystal composition containing at least one polymerizable liquid crystal compound in a liquid crystal state, irradiating active energy rays such as ultraviolet rays in that state.
  • active energy rays such as ultraviolet rays
  • a polymer obtained by immobilizing the alignment structure of the liquid crystal molecules can be obtained.
  • the polymer obtained in this way has anisotropy of physical properties such as refractive index, dielectric constant, magnetization rate, elasticity rate and thermal expansion rate, and thus can be used as an optical anisotropic body such as retardation film, polarizing plate, polarizing prism, brightness enhancement film, coating material of optical fiber and the like.
  • the inventors of the present invention have repeatedly studied the liquid crystal compound, polymerizable liquid crystal compound having a chemical structure as shown in the following formula (1), in particular having a central benzene ring in which an alkyl substituent is introduced, at least one imine linking group and naphthalene ring linking group in the main chain
  • the polymerizable liquid crystal compound not only has a high birefringence but also has excellent orientation in coating, enabling the manufacture of an optically anisotropic body having a thin thickness and excellent optical properties, thereby completing the present invention.
  • a polymerizable liquid crystal compound represented by Chemical Formula 1 is provided:
  • A is an alkyl group having 1 to 10 carbon atoms
  • D 1 , D 2 , G 1 and G 2 are each independently a single bond or a divalent linking group, wherein at least one of D 1 , D 2 , G 1 and G 2 is an imine group;
  • E 1 and E 2 are each independently a benzene ring or a naphthalene ring, and at least one of E 1 and E 2 is a naphthalene ring;
  • J 1 and J 2 are each independently an alkylene group of 1 to 10 carbohydrates
  • L 1 and L 2 are each independently a hydrogen group or a polymerizable group.
  • the polymerizable liquid crystal compound represented by Chemical Formula 1 may have a structure in which at least one imine linking group is introduced into a compound in which a condensed ring is introduced into mesogen, thereby exhibiting high birefringence and excellent orientation in coating. have.
  • A is a substituent bonded to the central benzene ring of the compound, and the polymerizable liquid crystal compound may have more excellent orientation, and may reduce light leakage of the retardation film manufactured using the same.
  • A may be an alkyl group having 1 to 10 carbon atoms, preferably an alkyl group having 1 to 6 carbon atoms, more preferably an alkyl group having 1 to 3 carbon atoms.
  • D 1 , D 2 , G 1, and G 2 may be each independently a single bond or a divalent linking group.
  • the polymerizable liquid crystal compound of the exemplary embodiment may include 3 ⁇ 4 NMR spectrum having at least one peak at ⁇ of 8.0 ppm to 8.5 ppm as including at least one imine group.
  • ⁇ 1 and ⁇ 2 are each independently a benzene ring or a naphthalene ring, at least one of ⁇ 1 and ⁇ 2 may be a naphthalene ring, and preferably, the ⁇ 1 and ⁇ 2 are each naphthalene ring. Can be.
  • the polymerizable liquid crystal compound of the embodiment has a central benzene ring in which an alkyl substituent is introduced, and in particular, has a structure in which at least one imine linking group and a naphthalene ring linking group are simultaneously introduced into the main chain. Accordingly, the polymerizable liquid crystal compound of the above embodiment can exhibit not only higher birefringence by synergism by these substituents and linking groups, but also excellent orientation when coating the composition including the same, and the thickness is thin. It is possible to manufacture an optically anisotropic body having excellent optical properties.
  • J 1 and J 2 may each independently be an alkylene group having 1 to 10 carbon atoms, preferably an alkylene group having 2 to 9 carbon atoms, and more preferably an alkylene group having 3 to 6 carbon atoms. Can be.
  • L 1 and L 2 may be each independently hydrogen or a polymerizable group, wherein the 'polymerizable group' refers to any functional group capable of crosslinking or polymerizing such as an unsaturated bond or a (meth) acrylate group. It can be defined as.
  • L1 and L2 may each independently be a hydrogen group, an acrylate group, a methacrylate group, an epoxy group, or the like.
  • Specific examples of the polymerizable liquid crystal compound represented by Chemical Formula 1 include the following Chemical Formulas 2a and 2b.
  • R 1 and R 2 may be each independently an alkyl group having 1 to 10 carbon atoms, and n may be an integer of 1 to 10, respectively.
  • the polymerizable liquid crystal compound of the present invention is not limited only to the following exemplary compounds.
  • the polymerizable liquid crystal compound represented by Chemical Formula 1 may be prepared by applying a known reaction, which will be described in detail in the Examples of the present specification.
  • a polymerizable liquid crystal composition comprising the compound represented by Formula 1 is provided.
  • composition according to the present invention includes a compound represented by Formula 1, which is a polymerizable liquid crystal monomer, and the compound represented by Formula 1, alone or in combination of two or more, may be homopolymerized or copolymerized.
  • the composition may further include any liquid crystal compound in addition to the compound represented by Chemical Formula 1, and the arbitrary liquid crystal compound may be polymerizable or non-polymerizable.
  • the arbitrary liquid crystal compound the liquid crystal compound which has an ethylenically unsaturated bond, the compound which has an optical active group, a rod-like liquid crystal compound, etc. are mentioned.
  • the arbitrary liquid crystal compounds may be mixed in an appropriate amount according to their structure, preferably, so that the compound represented by the formula (1) according to the present invention is included in more than 60% by weight of the total monomer weight, It is more advantageous in terms of achieving one object.
  • an optically anisotropic body including a cured product or polymer of the polymerizable liquid crystal compound of Formula 1 is provided.
  • the optically anisotropic body may include a cured product or polymer in which at least a part of the terminal polymerizable group of the polymerizable liquid crystal compound of Chemical Formula 1 is additionally polymerized or crosslinked.
  • the optically anisotropic body according to the present invention includes a cured product or a polymerized body of the above-described polymerizable liquid crystal compound, and exhibits a high retardation value, but may have no light leakage phenomenon or minimize it.
  • the optically anisotropic body according to the present invention can be manufactured in a simpler process with a thin thickness as compared with the previous laminated optical anisotropic body.
  • the optically anisotropic body may be prepared by coating and drying the polymerizable liquid crystal composition on a support, orienting the liquid crystal compound, and then polymerizing by irradiating ultraviolet rays or the like.
  • the support is not particularly limited, but preferably, a glass plate, a polyetherine terephthalate film, or a cellulose-based film spout may be used.
  • a method of applying the polymerizable liquid crystal composition to a support a known method may be applied without particular limitation. For example, a coating method, a spin coating method, a bar coating method, a spray coating method, or the like may be applied.
  • a known method for orienting the polymerizable liquid crystal composition a known method such as a method of rubbing the formed composition layer or applying a magnetic field or an electric field to the formed composition layer may be applied.
  • the thickness of the optically anisotropic body can be adjusted according to the use, preferably can be adjusted in the range of 0.01 to 100 kHz.
  • Such optically anisotropic medium of the present invention used as an optical element such as a phase difference film, an optical compensating plate of the liquid crystal display device, an alignment film, a polarizing plate, a viewing angle enlargement plate, a reflecting film, color filters, holographic elements, optical polarization prism, an optical head Can be.
  • an optical element such as a phase difference film, an optical compensating plate of the liquid crystal display device, an alignment film, a polarizing plate, a viewing angle enlargement plate, a reflecting film, color filters, holographic elements, optical polarization prism, an optical head Can be.
  • the NMR spectrum of the compound RM-01 is as follows.
  • the structure of the compound RM-01 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, the temperature was changed to a nematic phase of the crystalline phase at about 167 ° C., the isotropic liquid crystal phase appeared when it exceeds about 181 ° C. In this way, it was confirmed that compound RM- forms a nematic phase in the temperature range of about 167 ° C to 181 ° C.
  • the NMR spectrum of the compound RM-02 is as follows.
  • the NMR spectrum of the compound RM-03 is as follows.
  • the NMR spectrum of the compound RM-04 is as follows.
  • compound RM-04 forms a nematic phase in the temperature range of about 178 ° C to 189 ° C.
  • Example 17 Synthesis of Compound R3 ⁇ 4H) 5
  • the NMR spectrum of the compound RM-05 is as follows.
  • the NMR spectrum of the compound RM-06 is as follows.
  • the NMR spectrum of the compound RM-07 is as follows.
  • the NMR spectrum of the compound RM-08 is as follows.
  • the NMR spectrum of the compound RM-09 is as follows.
  • the NMR spectrum of the compound RM-10 is as follows.
  • Compound 17 was prepared by the same method and conditions as in Example 3, except that Compound 16 according to Comparative Example 11 was used instead of Compound 3-a. Got it.
  • Example 7 About 12 g of Compound RM-11 was obtained by the same method and conditions as in Example 7, except that Compound 17 according to Comparative Example 12 was used instead of Compound 4-a.
  • the NMR spectrum of the compound RM-11 is as follows.
  • the NMR spectrum of the compound RM-12 is as follows.
  • a polymerizable liquid crystal composition including a balance of CPO cyclopentanone
  • the liquid crystal composition was coated on a norbornene-based photoalignment material-coated COP (cycloolefin polymer) film by a coating method, and then dried at about 90 ° C. for 2 minutes to align the liquid crystal compound. Thereafter, the film was irradiated with non-polarized UV light having a high pressure mercury lamp of 200 mW / ciif as a light source to fix the alignment state of the liquid crystal to prepare a retardation film.
  • Retardation films were prepared in the same manner as in Preparation Examples 1 to 8, except that Compound RM-09, RM-10, RM-11, or RM-12 according to Comparative Examples was used instead of Compound RM-01.
  • a retardation film was manufactured in the same manner as in Preparation Examples 1 to 8, except that the polymerizable liquid crystal compound (RM 257, manufactured by ⁇ RUILIAN MODERN Co., Ltd) was used instead of the compound RM-01.
  • the retardation film including the compounds RM-01 to RM-08 according to Preparation Examples 1 to 8 has a light leakage phenomenon compared to the films of Comparative Preparation Examples 1 to 4 and Reference Examples. It was confirmed that almost did not appear either.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polarising Elements (AREA)

Abstract

The present invention relates to a polymerizable liquid crystal compound, and to a liquid crystal composition and optically anisotropic body comprising same. The polymerizable liquid crystal compound according to the present invention makes it possible to produce an optically anisotropic body that not only has a high birefractive index but also has outstanding orientation properties during coating and has outstanding optical properties despite being thin.

Description

【명세서】  【Specification】
【발명의 명칭】  [Name of invention]
중합성 액정 화합물, 이를 포함하는 액정 조성물 및 광학 이방체 【기술분야】  Polymerizable liquid crystal compound, liquid crystal composition and optically anisotropic body comprising the same
본 발명은 중합성 액정 화합물, 이를 포함하는 액정 조성물 및 광학 이방체에 관한 것이다.  The present invention relates to a polymerizable liquid crystal compound, a liquid crystal composition comprising the same and an optically anisotropic body.
【배경기술】 ' [Background Art] "
위상 지연기 (phase retarder)는 이를 통과하는 빛의 편광 상태를 바꾸어주는 광학 소자의 일종으로 파장판 (wave plate)이라고도 한다. 전자기파가 위상 지연기를 통과하면 편광 방향 (전기장 백터 방향)이 광축에 평행하거나 수직한 두 성분 (정상광선과 이상광선)의 합이 되고, 위상 지연기의 복굴절과 두께에 따라 두 성분의 백터합이 변하게 되므로 통과한 후의 편광 방향이 달라지게 된다.  A phase retarder is a type of optical device that changes the polarization state of light passing through it, also called a wave plate. When the electromagnetic wave passes through the phase retarder, the polarization direction (field vector direction) is the sum of two components (normal and extraordinary) parallel or perpendicular to the optical axis, and the vector sum of the two components depends on the birefringence and thickness of the phase retarder. Since it changes, the polarization direction after passing is different.
최근 위상 지연기 등에 사용되는 광학 필름의 제조에 관한 큰 이슈 중 하나는 적은 비용으로 고성능의 필름올 제조하는 것이다. 광학 필름의 제조시 높은 복굴절율을 가지는 액정 화합물을 사용할 경우, 적은 양의 액정 화합물로도 필요로 하는 위상차 값의 구현이 가능하기 때문이다. 또한, 이러한 액정 화합물을 사용할 경우, 보다 얇은 박층의 필름을 제조할 수 있기 때문이다.  One of the major issues related to the production of optical films used in phase retarders and the like in recent years is the production of high performance films at low cost. This is because when a liquid crystal compound having a high birefringence is used in manufacturing the optical film, it is possible to realize a phase difference value even with a small amount of the liquid crystal compound. Moreover, when using such a liquid crystal compound, a thinner thin film can be manufactured.
· 이에 높은 복굴절율을 가지는 액정 화합물을 얻기 위한 연구가 활발히 진행되고 있으나, 이전의 액정 화합물은 필름에 코팅될 경우 막의 배향성 문제 등으로 인해 산업계에 실제 적용하기에 한계가 있는 실정이다. 【발명의 내용] To this end, studies to obtain a liquid crystal compound having a high birefringence have been actively conducted. However, when the liquid crystal compound is coated on a film, there is a limit to the practical application in the industry due to the problem of the orientation of the film. [Contents of the Invention]
【해결하려는 과제】  [Problem to solve]
이에 본 발명은 높은 복굴절율을 가지면서도 코팅시 배향성이 우수한 중합성 액정 화합물을 제공하기 위한 것이다.  Accordingly, the present invention is to provide a polymerizable liquid crystal compound having high birefringence and excellent in orientation during coating.
또한, 본 발명은 상기 화합물을 포함하는 중합성 액정 조성물을 제공하기 위한 것이다.  Moreover, this invention is providing the polymerizable liquid crystal composition containing the said compound.
또한, 본 발명은 상기 중합성 액정 조성물의 중합체를 포함하는 광학 이방체를 제공하기 위한 것이다. 【과제의 해결 수단】 Moreover, this invention is providing the optically anisotropic body containing the polymer of the said polymeric liquid crystal composition. [Measures of problem]
본 발명에 따르면, 하기 화학식 1로 표시되는 중합성 액정 화합물 0 제공된다:  According to the present invention, a polymerizable liquid crystal compound 0 represented by Formula 1 is provided:
Figure imgf000004_0001
Figure imgf000004_0001
상기 화학식 1에서,  In Chemical Formula 1,
A는 탄소수 1 내지 10의 알킬기이고;  A is an alkyl group having 1 to 10 carbon atoms;
D1, D2, G1 및 G2는 각각 독립적으로 단일 결합 또는 2가의 연결기로서, 상기 D1, D2, G1 및 G2 중 적어도 하나는 이민기이고; D 1 , D 2 , G 1 and G 2 are each independently a single bond or a divalent linking group, wherein at least one of D 1 , D 2 , G 1 and G 2 is an imine group;
E1 및 E2는 각각 독립적으로 벤젠환 또는 나프탈렌환으로서, 상기 E1 및 E2 중 적어도 하나는 나프탈렌환이고; E 1 and E 2 are each independently a benzene ring or a naphthalene ring, and at least one of E 1 and E 2 is a naphthalene ring;
J1 및 J2는 각각 독립적으로 탄수소 1 내지 10의 알킬렌기이고; J 1 and J 2 are each independently an alkylene group of 1 to 10 carbohydrates;
L1 및 L2는 각각 독립적으로 수소 또는 중합성기이다. L 1 and L 2 are each independently hydrogen or a polymerizable group.
또한, 본 발명의 다른 구현예에 따르면, 상기 화학식 1로 표시되는 화합물을 포함하는 중합성 액정 조성물이 제공된다.  In addition, according to another embodiment of the present invention, a polymerizable liquid crystal composition including the compound represented by Chemical Formula 1 is provided.
그리고, 본 발명의 또 다른 구현예에 따르면, 상기 증합성 액정 화합물의 경화물 또는 중합체를 포함하는 광학 이방체가 제공된다.  In addition, according to another embodiment of the present invention, an optically anisotropic body including a cured product or a polymer of the polymerizable liquid crystal compound is provided.
[발명의 효과]  [Effects of the Invention]
본 발명에 따른 중합성 액정 화합물은 높은 복굴절율을 가질 뿐 아니라 코팅시 배향성이 우수하여, 두께가 얇으면서도 광학적 물성이 우수한 광학 이방체의 제조를 가능케 한다.  The polymerizable liquid crystal compound according to the present invention not only has a high birefringence but also has excellent orientation in coating, thereby enabling the production of an optically anisotropic body having a thin thickness and excellent optical properties.
【도면의 간단한 설명】  [Brief Description of Drawings]
도 1 및 도 2는 본 발명의 일 실시예 및 비교예에 따른 화합물을 포함하는 위상차 필름에 대하여 빛샘 정도를 확인하기 위해 시험예 2의 방법으로 촬영한사진이다.  1 and 2 are photographs taken by the method of Test Example 2 to confirm the degree of light leakage with respect to the retardation film containing a compound according to an embodiment and a comparative example of the present invention.
【발명을 실시하기 위한 구체적인 내용】  [Specific contents to carry out invention]
이하, 본 발명의 구현 예들에 따른 중합성 액정 화합물, 이를 포함하는 액정 조성물 및 광학 이방체에 대하여 설명하기로 한다 . Hereinafter, a polymerizable liquid crystal compound according to embodiments of the present invention, The liquid crystal composition and optically anisotropic body to be included will be described.
그에 앞서, 본 명세서 전체에서 명시적인 언급이 없는 한, 전문용어는 단지 특정 구현예를 언급하기 위한 것이며, 본 발명을 한정하는 것을 의도하지 않는다 .  Prior to this, the terminology is for the purpose of describing particular embodiments only and is not intended to limit the invention, unless expressly stated throughout this specification.
그리고, 여기서 사용되는 단수 형태들은 문구들이 이와 명백히 반대의 의미를 나타내지 않는 한 복수 형태들도 포함한다.  As used herein, the singular forms “a,” “an,” and “the” include plural forms as well, unless the phrases clearly indicate the opposite.
또한, 명세서에서 사용되는 '포함 '의 의미는 특정 특성, 영역, 정수, 단계, 동작, 요소 또는 성분을 구체화하며, 다른 특정 특성, 영역, 정수, 단계, 동작, 요소, 또는 성분의 부가를 제외시키는 것은 아니다.  In addition, the meaning of "included" as used in the specification specifies a specific characteristic, region, integer, step, operation, element or component, excluding the addition of other specific characteristics, region, integer, step, operation, element, or component. It is not meant to be.
한편, '중합성 액정 화합물 '은 중합성 관능기를 가지는 액정 화합물로서, 상기 중합성 액정 화합물을 적어도 1종 함유하는 액정 조성물을 액정 상태로 배향시킨 후, 그 상태에서 자외선 등의 활성에너지선을 조사하면, 액정 분자의 배향 구조를 고정화한 중합물을 얻을 수 있다. 이렇게 얻어진 중합물은 굴절율, 유전율, 자화율, 탄성율, 열팽창율 등의 물리적 성질의 이방성을 가지고 있으므로, 예를 들어 위상차관, 편광판, 편광 프리즘, 휘도 향상 필름, 광 섬유의 피복재 등의 광학 이방체로서 웅용 가능하다. 그리고, 이러한 중합물의 이방성 이외에도, 예를 들면 투명성, 강도, 도포성, 용해도, 결정화도, 내열성 등의 물성도 중요하다. 본 발명자들은 액정 화합물에 대한 연구를 거듭한 결과, 하기 화학식 1과 같은 화학구조를 가지는 중합성 액정 화합물, 특히 알킬 치환기가 도입된 중심 벤젠환을 가지며, 주쇄에 적어도 하나의 이민 연결기와 나프탈렌환 연결기를 동시에 가지는 중합성 액정 화합물은 높은 복굴절율을 가질 뿐 아니라 코팅시 배향성이 우수하여, 두께가 얇으면서도 광학적 물성이 우수한 광학 이방체의 제조를 가능케 함올 확인하고, 본 발명을 완성하였다.  Meanwhile, the 'polymerizable liquid crystal compound' is a liquid crystal compound having a polymerizable functional group, and after aligning a liquid crystal composition containing at least one polymerizable liquid crystal compound in a liquid crystal state, irradiating active energy rays such as ultraviolet rays in that state. In this case, a polymer obtained by immobilizing the alignment structure of the liquid crystal molecules can be obtained. The polymer obtained in this way has anisotropy of physical properties such as refractive index, dielectric constant, magnetization rate, elasticity rate and thermal expansion rate, and thus can be used as an optical anisotropic body such as retardation film, polarizing plate, polarizing prism, brightness enhancement film, coating material of optical fiber and the like. Do. In addition to the anisotropy of such a polymer, physical properties such as transparency, strength, applicability, solubility, crystallinity, and heat resistance are also important. The inventors of the present invention have repeatedly studied the liquid crystal compound, polymerizable liquid crystal compound having a chemical structure as shown in the following formula (1), in particular having a central benzene ring in which an alkyl substituent is introduced, at least one imine linking group and naphthalene ring linking group in the main chain At the same time, the polymerizable liquid crystal compound not only has a high birefringence but also has excellent orientation in coating, enabling the manufacture of an optically anisotropic body having a thin thickness and excellent optical properties, thereby completing the present invention.
이와 같은 본 발명의 일 구현 예쎄 따르면, 하기 화학식 1로 표시되는 중합성 액정 화합물이 제공된다:  According to one embodiment of the present invention, a polymerizable liquid crystal compound represented by Chemical Formula 1 is provided:
[화학식 1]
Figure imgf000006_0001
상기 화학식 l에서,
[Formula 1]
Figure imgf000006_0001
In Chemical Formula l,
A는 탄소수 1 내지 10의 알킬기이고;  A is an alkyl group having 1 to 10 carbon atoms;
D1, D2, G1 및 G2는 각각 독립적으로 단일 결합 또는 2가의 연결기로서, 상기 D1, D2, G1 및 G2 중 적어도 하나는 이민기이고; D 1 , D 2 , G 1 and G 2 are each independently a single bond or a divalent linking group, wherein at least one of D 1 , D 2 , G 1 and G 2 is an imine group;
E1 및 E2는 각각 독립적으로 벤젠환 또는 나프탈렌환으로서, 상기 E1 및 E2 중 적어도 하나는 나프탈렌환이고; E 1 and E 2 are each independently a benzene ring or a naphthalene ring, and at least one of E 1 and E 2 is a naphthalene ring;
J1 및 J2는 각각 독립적으로 탄수소 1 내지 10의 알킬렌기이고; J 1 and J 2 are each independently an alkylene group of 1 to 10 carbohydrates;
L1 및 L2는 각각 독립적으로 수소기 또는 중합성기이다. 상기 화학식 1로 표시되는 중합성 액정 화합물은 메조겐에 축합환이 도입된 화합물에 적어도 하나의 이민 연결기가 도입된 구조를 가질 수 있는 것으로서, 그에 따라 높은 복굴절율을 나타내면서도 코팅시 우수한 배향성을 나타낼 수 있다. L 1 and L 2 are each independently a hydrogen group or a polymerizable group. The polymerizable liquid crystal compound represented by Chemical Formula 1 may have a structure in which at least one imine linking group is introduced into a compound in which a condensed ring is introduced into mesogen, thereby exhibiting high birefringence and excellent orientation in coating. have.
본 발명에 따르면, 상기 화학식 1에서 A는 화합물의 중심 벤젠환에 결합된 치환기로서, 중합성 액정 화합물이 보다 우수한 배향성을 갖도록 하며, 이를 사용하여 제조된 위상차 필름의 빛샘 현상이 적어지도록 할 수 있다. 일 구현 예에 따르면, 상기 A는 탄소수 1 내지 10의 알킬기일 수 있고, 바람직하게는 탄소수 1 내지 6의 알킬기, 보다 바람직하게는 탄소수 1 내지 3의 알킬기일 수 있다.  According to the present invention, in Chemical Formula 1, A is a substituent bonded to the central benzene ring of the compound, and the polymerizable liquid crystal compound may have more excellent orientation, and may reduce light leakage of the retardation film manufactured using the same. . According to one embodiment, A may be an alkyl group having 1 to 10 carbon atoms, preferably an alkyl group having 1 to 6 carbon atoms, more preferably an alkyl group having 1 to 3 carbon atoms.
그리고, 상기 화학식 1에서 D1, D2, G1 및 G2는 각각 독립적으로 단일 결합 또는 2가의 연결기일 수 있다. 여기서, 상기 '2가의 연결기 '는 -CH=N -, -0-, -S -, -CO-, -C00-, -0C0-, -0-C00-, -C0-NR-, -NR-C0-, -NR-C0-NR-, - 0CH2-, -CH2O-, -SCH-, -CH2S -, -CF20-, _0CF2-, _CF2S -, -SCF2-, -CH2CH2-, - (C¾)3-, -(CH2)4-, -CF2CH2-, -CH2CF2-, -CF2CF2-, -C=C- 또는 -C≡C- 일 수 있으며, 상기 R은 각각 독립적으로 수소 또는 탄소수 1 내지 10의 알킬기일 수 있다. 특히, 본 발명에 따르면, 상기 D1, D2, G1 및 G2 중 적어도 하나는 이민기 (_CH=N-)일 수 있으며, 바람직하게는, 상기 D1 과 D2, 또는 G1 과 G2 는 각각 이민기일 수 있다. 상기 일 구현 예의 중합성 액정 화합물은 적어도 하나의 이민기를 포함함에 따라, 8.0 ppm 내지 8.5 ppm의 δ에서 적어도 하나의 피크를 갖는 ¾ NMR스펙트럼을 나타낼 수 있다. In addition, in Formula 1, D 1 , D 2 , G 1, and G 2 may be each independently a single bond or a divalent linking group. Here, the divalent linking group is -CH = N-, -0-, -S-, -CO-, -C00-, -0C0-, -0-C00-, -C0-NR-, -NR- C0-, -NR-C0-NR-,-0CH 2- , -CH 2 O-, -SCH-, -CH 2 S-, -CF 2 0-, _0CF 2- , _CF 2 S-, -SCF 2 -, -CH 2 CH 2 -,-(C¾) 3 -,-(CH 2 ) 4- , -CF 2 CH 2- , -CH 2 CF 2- , -CF 2 CF 2- , -C = C- Or -C≡C-, wherein R can be each independently hydrogen or an alkyl group having 1 to 10 carbon atoms. In particular, according to the present invention, at least one of the D 1 , D 2 , G 1 and G 2 It may be an imine group (_CH = N-), and preferably, the D 1 and D 2 , or G 1 and G 2 may each be an imine group. The polymerizable liquid crystal compound of the exemplary embodiment may include ¾ NMR spectrum having at least one peak at δ of 8.0 ppm to 8.5 ppm as including at least one imine group.
또한, 상기 화학식 1에서 Ε1 및 Ε2는 각각 독립적으로 벤젠환 또는 나프탈렌환으로서, 상기 Ε1 및 Ε2 중 적어도 하나는 나프탈렌환일 수 있고, 바람직하게는 상기 Ε1 및 Ε2는 각각 나프탈렌환일 수 있다. In addition, in Formula 1, Ε 1 and Ε 2 are each independently a benzene ring or a naphthalene ring, at least one of Ε 1 and Ε 2 may be a naphthalene ring, and preferably, the Ε 1 and Ε 2 are each naphthalene ring. Can be.
즉, 상기 일 구현 예의 중합성 액정 화합물은 알킬 치환기가 도입된 중심 벤젠환을 가지며, 특히 주쇄에 적어도 하나의 이민 연결기와 나프탈렌환 연결기가 동시에 도입된 구조를 갖는다. 그에 따라 상기 일 구현 예의 중합성 액정 화합물은 이들 치환기 및 연결기들에 의한 상승 작용에 의해 보다 높은 복굴절율을 나타낼 수 있을 뿐 아니라, 이를 포함하는 조성물의 코팅시 우수한 배향성올 나타낼 수 있어, 두께가 얇으면서도 광학적 물성이 우수한 광학 이방체의 제조를 가능케 한다.  That is, the polymerizable liquid crystal compound of the embodiment has a central benzene ring in which an alkyl substituent is introduced, and in particular, has a structure in which at least one imine linking group and a naphthalene ring linking group are simultaneously introduced into the main chain. Accordingly, the polymerizable liquid crystal compound of the above embodiment can exhibit not only higher birefringence by synergism by these substituents and linking groups, but also excellent orientation when coating the composition including the same, and the thickness is thin. It is possible to manufacture an optically anisotropic body having excellent optical properties.
한편, 상기 화학식 1에서 상기 J1 및 J2는 각각 독립적으로 탄소수 1 내지 10의 알킬렌기일 수 있고, 바람직하게는 탄소수 2 내지 9의 알킬렌기, 보다 바람직하게는 탄소수 3 내지 6의 알킬렌기일 수 있다. Meanwhile, in Formula 1, J 1 and J 2 may each independently be an alkylene group having 1 to 10 carbon atoms, preferably an alkylene group having 2 to 9 carbon atoms, and more preferably an alkylene group having 3 to 6 carbon atoms. Can be.
그리고, 상기 화학식 1에서 상기 L1 및 L2는 각각 독립적으로 수소 또는 중합성기일 수 있는데, 여기서 상기 '중합성기'는 불포화 결합 또는 (메트)아크릴레이트기 등과 같이 가교 또는 중합 가능한 임의의 작용기를 의미하는 것으로 정의될 수 있다. 본 발명에 따르면, 상기 L1 및 L2는 각각 독립적으로 수소기, 아크릴레이트기, 메타크릴레이트기, 에폭시기 등일 수 있다. ― 상기 화학식 1로 표시되는 중합성 액정 화합물의 구체예들로는 하기 화학식 2a 및 2b를 들 수 있다. 하기 화학식 2a 및 2b에서 R1 및 R2는 각각 독립적으로 탄소수 1 내지 10의 알킬기일 수 있고, n은 각각 1 내지 10의 정수일 수 있다. 다만 본 발명의 중합성 액정 화합물을 이하의 예시 화합물들만으로 한정하는 것은 아니다. In addition, in Formula 1, L 1 and L 2 may be each independently hydrogen or a polymerizable group, wherein the 'polymerizable group' refers to any functional group capable of crosslinking or polymerizing such as an unsaturated bond or a (meth) acrylate group. It can be defined as. According to the present invention, L1 and L2 may each independently be a hydrogen group, an acrylate group, a methacrylate group, an epoxy group, or the like. Specific examples of the polymerizable liquid crystal compound represented by Chemical Formula 1 include the following Chemical Formulas 2a and 2b. In Formulas 2a and 2b, R 1 and R 2 may be each independently an alkyl group having 1 to 10 carbon atoms, and n may be an integer of 1 to 10, respectively. However, the polymerizable liquid crystal compound of the present invention is not limited only to the following exemplary compounds.
[화학식 2a] [Formula 2a]
Figure imgf000008_0001
한편, 상기 화학식 1로 표시되는 중합성 액정 화합물은 공지의 반웅을 응용하여 제조될 수 있는데, 보다 상세한 제조 방법에 대해서는 본 명세서의 실시예 부분에서 상술한다. 한편, 본 발명의 다른 구현 예에 따르면, 상기 화학식 1로 표시되는 화합물을 포함하는 중합성 액정 조성물이 제공된다.
Figure imgf000008_0001
Meanwhile, the polymerizable liquid crystal compound represented by Chemical Formula 1 may be prepared by applying a known reaction, which will be described in detail in the Examples of the present specification. On the other hand, according to another embodiment of the present invention, a polymerizable liquid crystal composition comprising the compound represented by Formula 1 is provided.
본 발명에 따른 상기 조성물은 중합성 액정 단량체인 화학식 1로 표시되는 화합물을 포함하는 것으로서, 상기 화학식 1로 표시되는 화합물을 단독 또는 2종 이상을 조합하여, 단독 중합 또는 공중합시킬 수 있다.  The composition according to the present invention includes a compound represented by Formula 1, which is a polymerizable liquid crystal monomer, and the compound represented by Formula 1, alone or in combination of two or more, may be homopolymerized or copolymerized.
그리고, 상기 조성물은 상기 화학식 1로 표시되는 화합물 이외에, 임의의 액정 화합물을 더욱 포함할 수 있으며, 상기 임의의 액정 화합물은 중합성을 갖거나 갖지 않는 것일 수 있다. 여기서, 상기 임의의 액정 화합물로는 에틸렌성 불포화 결합을 가지는 액정 화합물, 광학 활성기를 가지는 화합물, 봉상 액정 화합물 등을 예로 들 수 있다.  The composition may further include any liquid crystal compound in addition to the compound represented by Chemical Formula 1, and the arbitrary liquid crystal compound may be polymerizable or non-polymerizable. Here, as said arbitrary liquid crystal compound, the liquid crystal compound which has an ethylenically unsaturated bond, the compound which has an optical active group, a rod-like liquid crystal compound, etc. are mentioned.
이때, 상기 임의의 액정 화합물은 그들의 구조에 따라 적절한 양으로 흔합될 수 있는데, 바람직하게는 본 발명에 따른 상기 화학식 1로 표시되는 화합물이 전체 단량체 중량의 60 중량 % 이상으로 포함되도록 하는 것이, 전술한 목적 달성 측면에서 보다 유리하다.  At this time, the arbitrary liquid crystal compounds may be mixed in an appropriate amount according to their structure, preferably, so that the compound represented by the formula (1) according to the present invention is included in more than 60% by weight of the total monomer weight, It is more advantageous in terms of achieving one object.
또한, 상기 중합성 액정 조성물에는 필요에 따라 용매, 중합 개시제, 보존 안정제, 액정 배향 조제, 염료, 안료 등이 더욱 첨가될 수 있으며, 상기 첨가제는 본 발명이 속하는 기술분야에서 통상적인 성분들일 수 있으므로, 그 구성을 특별히 한정하지 않는다. 한편, 본 발명의 또 다른 구현 예에 따르면, 상기 화학식 1의 중합성 액정 화합물의 경화물 또는 중합체를 포함하는 광학 이방체가 제공된다. 상기 광학 이방체는 상기 화학식 1의 중합성 액정 화합물의 말단 중합성기의 적어도 일부가 부가 중합 또는 가교되어 있는 경화물 또는 중합체를 포함하는 것일 수 있다. In addition, a solvent, a polymerization initiator, a storage stabilizer, a liquid crystal alignment aid, a dye, and a pigment may be further added to the polymerizable liquid crystal composition, and the additive may be conventional components in the art to which the present invention pertains. Therefore, the configuration is not particularly limited. On the other hand, according to another embodiment of the present invention, an optically anisotropic body including a cured product or polymer of the polymerizable liquid crystal compound of Formula 1 is provided. The optically anisotropic body may include a cured product or polymer in which at least a part of the terminal polymerizable group of the polymerizable liquid crystal compound of Chemical Formula 1 is additionally polymerized or crosslinked.
특히, 본 발명에 따른 광학 이방체는 전술한 증합성 액정 화합물의 경화물 또는 증합체를 포함함에 따라, 높은 위상차 값을 나타내면서도 빛샘 현상이 없거나 최소화될 수 있다. 또한, 본 발명에 따른 광학 이방체는, 이전의 라미네이트형 광학 이방체에 비하여, 두께가 얇으면서도 보다 단순화된 공정으로 제조될 수 있다. 한편, 상기 광학 이방체는 상기 중합성 액정 조성물을 지지체 상에 도포 및 건조하고, 액정 화합물을 배향 시킨 후, 자외선 등을 조사하여 중합시킴으로써 제조될 수 있다.  In particular, the optically anisotropic body according to the present invention includes a cured product or a polymerized body of the above-described polymerizable liquid crystal compound, and exhibits a high retardation value, but may have no light leakage phenomenon or minimize it. In addition, the optically anisotropic body according to the present invention can be manufactured in a simpler process with a thin thickness as compared with the previous laminated optical anisotropic body. On the other hand, the optically anisotropic body may be prepared by coating and drying the polymerizable liquid crystal composition on a support, orienting the liquid crystal compound, and then polymerizing by irradiating ultraviolet rays or the like.
여기서, 상기 지지체는 특별히 한정되지 않으나, 바람직하게는 유리판, 폴리에텔린테레프탈레이트 필름 , 셀를로오스계 필름 둥이 이용될 수 있다. 그리고, 상기 중합성 액정 조성물을 지지체에 도포하는 방법으로는 공지의 방법이 특별한 제한 없이 적용될 수 있으며, 예를 들면 를 코팅법, 스핀 코팅법, 바 코팅법, 스프레이 코팅법 등이 적용될 수 있다. 또한, 상기 중합성 액정 조성물을 배향시키는 방법으로는 형성된 조성물층을 러빙 (rubbing) 처리하거나, 형성된 조성물층에 자장이나 전장 등을 인가하는 방법 등 공지의 방법이 적용될 수 있다.  Here, the support is not particularly limited, but preferably, a glass plate, a polyetherine terephthalate film, or a cellulose-based film spout may be used. In addition, as a method of applying the polymerizable liquid crystal composition to a support, a known method may be applied without particular limitation. For example, a coating method, a spin coating method, a bar coating method, a spray coating method, or the like may be applied. In addition, as the method for orienting the polymerizable liquid crystal composition, a known method such as a method of rubbing the formed composition layer or applying a magnetic field or an electric field to the formed composition layer may be applied.
그리고, 상기 광학 이방체는 용도에 따라 그 두께가 조절될 수 있는데, 바람직하게는 0.01 내지 100 皿의 범위로 조절될 수 있다.  And, the thickness of the optically anisotropic body can be adjusted according to the use, preferably can be adjusted in the range of 0.01 to 100 kHz.
이와 같은 본 발명의 광학 이방체는 액정 표시장치의 위상차 필름, 광학 보상판, 배향막, 편광판, 시야각 확대판, 반사 필름, 컬러 필터, 홀로그래픽 소자, 광편광 프리즘, 광 헤드 등의 광학 소자로 '사용될 수 있다. 이하, 본 발명에 따른 구체적인 실시예를 통해, 발명의 작용 및 효과를 보다 상세히 서술하기로 한다. 다만, 이러한 실시예는 발명의 예시로 제시된 것에 불과하며, 이에 의해 발명의 권리범위가 정해지는 것은 아니다. Such optically anisotropic medium of the present invention, used as an optical element such as a phase difference film, an optical compensating plate of the liquid crystal display device, an alignment film, a polarizing plate, a viewing angle enlargement plate, a reflecting film, color filters, holographic elements, optical polarization prism, an optical head Can be. Hereinafter, the operation and effects of the invention will be described in more detail with reference to specific examples according to the present invention. However, these embodiments are only presented as an example of the invention, whereby the scope of the invention is not determined.
[Scheme 1: 실시예 1 ~실시예 10] Scheme 1: Example 1 to Example 10
Figure imgf000011_0001
실시예 1: 화합물 3-a의 합성
Figure imgf000011_0001
Example 1: Synthesis of Compound 3-a
상기 Scheme 1에서 화합물 l_a인 2-met hyl benzene- l,4_di amine [Journal of Chemical Research, 2005, 2, 123] 약 8g을 에탄을 약 80ml에 녹인 후, 약 90°C로 가열하였다. 여기에, 화합물 2인 6-hydroxy-2- naphthaldehyde 약 40g을 에탄을 약 150ml에 녹인 용액을 적가하였고, 약 8 시간 동안 환류 교반하였다. 반웅 흔합물을 상온으로 냉각시켜 고체 생성물을 얻었고, 이를 에탄을로 여과한 후 진공 건조하여 약 24g의 화합물 3-a (R^methyl)를 얻었다. 2-met hyl benzene- l, 4 _di amine which is the compound l_a in Scheme 1 [Journal of Chemical Research, 2005, 2, 123] After about 8 g of ethane was dissolved in about 80 ml, it was heated to about 90 ° C. Here, a solution of about 40 g of 6-hydroxy-2-naphthaldehyde as a compound 2 dissolved in about 150 ml of ethane was added dropwise, followed by stirring under reflux for about 8 hours. The reaction mixture was cooled to room temperature to obtain a solid product, which was filtered through ethane and dried in vacuo to yield about 24 g of compound 3-a (R ^ methyl).
실시예 2: 화합물 3-b의 합성  Example 2: Synthesis of Compound 3-b
화합물 1-a 대신 화합물 1-b인 2-ethylbenzene-l,4-diamine올 사용한 것을 제외하고, 실시예 1과 동일한 방법 및 조건으로 약 31g의 화합물 3-b (R^ethyl)를 얻었다. 실시예 3: 화합물 4-a의 합성  About 31 g of Compound 3-b (R ^ ethyl) was obtained by the same method and conditions as in Example 1, except that 2-ethylbenzene-l, 4-diamineol, which was Compound 1-b, was used instead of Compound 1-a. Example 3: Synthesis of Compound 4-a
실시예 1에 따른 화합물 3-a 약 10g, 3-클로로프로판올 약 6.6g, 및 포타슴 카보네이트 약 13g을 아세톤에 녹인 후, 약 24 시간 동안 환류 교반하였다. 반응 흔합물을 상온으로 냉각한 후, 여과하여 고체를 제거하고 감압 증류하였다. 그리고, 컬럼 크로마토그래프 정제를 통해 약 11.5g의 화합물 4-a (R^methyl , η=3)를 얻었다.  About 10 g of compound 3-a according to Example 1, about 6.6 g of 3-chloropropanol, and about 13 g of potassium carbonate were dissolved in acetone, followed by stirring under reflux for about 24 hours. The reaction mixture was cooled to room temperature, filtered to remove solids and distilled under reduced pressure. Then, about 11.5 g of Compound 4-a (R ^ methyl, η = 3) was obtained through column chromatography.
실시예 4: 화합물 4-b의 합성  Example 4: Synthesis of Compound 4-b
3-클로로프로판올 대신 6-클로로핵산올을 사용한 것을 제외하고, 실시예 3과 동일한 방법 및 조건으로 약 10.4g의 화합물 4-b (R^methyl , η=6)를 얻었다.  About 10.4 g of Compound 4-b (R ^ methyl, η = 6) was obtained by the same method and conditions as in Example 3, except that 6-chloronucleol was used instead of 3-chloropropanol.
실시예 5: 화합물 4-c의 합성  Example 5: Synthesis of Compound 4-c
화합물 3-a 대신 실시예 2에 따른 화합물 3-b를 사용한 것을 제외하고, 실시예 3과 동일한 방법 및 조건으로 약 12g의 화합물 4-c (R^ethyl , n=3)를 얻었다.  About 12 g of Compound 4-c (R ^ ethyl, n = 3) was obtained by the same method and conditions as in Example 3, except that Compound 3-b according to Example 2 was used instead of Compound 3-a.
실시예 6: 화합물 4-d의 합성  Example 6: Synthesis of Compound 4-d
화합물 3-a 대신 실시예 2에 따른 화합물 3-b를 사용하고, 3- 클로로프로판올 대신 6-클로로핵산올을 사용한 것을 제외하고, 실시예 3과 동일한 방법 및 조건으로 약 12.5g의 화합물 4-d (R^ethyl , η=6)를 얻었다. 실시예 7: 화합물 RM-이의 합성 About 12.5 g of Compound 4- in the same manner and conditions as in Example 3, except that Compound 3-b according to Example 2 was used instead of Compound 3-a and 6-chloronucleoanol was used instead of 3-chloropropanol d (R ^ ethyl, η = 6) was obtained. Example 7: Synthesis of Compound RM-It
실시예 3에 따른 화합물 4-a 약 10g을 디메틸아세트아마이드 약 100ml에 녹인 후, 약 0°C로 냉각시켰다. 여기에 아크릴로일클로라이드 약 3.3g을 30분에 걸쳐 적가하였고, 상온에서 약 2시간 동안 교반하였다. 상기 반웅용액을 디에틸에테르로 희석시킨 후, 염화나트륨 수용액으로 씻어주었다. 이로부터 유기 부분을 수거하였고, 화학적으로 건조한 후, 감압 증류하여 용매를 제거하였다. 수득된 생성물을 컬럼 크로마토그래프 정제하여 약 llg의 화합물 RM-01 (R^methyl , n=3)을 얻었다. About 10 g of Compound 4-a according to Example 3 was dissolved in about 100 ml of dimethylacetamide, and then cooled to about 0 ° C. About 3.3 g of acryloyl chloride was added dropwise over 30 minutes, and stirred at room temperature for about 2 hours. The reaction solution was diluted with diethyl ether and washed with an aqueous sodium chloride solution. The organic portion was collected therefrom, chemically dried, and then distilled under reduced pressure to remove the solvent. The obtained product was column chromatograph purified to obtain about llg of compound RM-01 (R ^ methyl, n = 3).
상기 화합물 RM-01에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-01 is as follows.
¾ NMR (CDC13) 표준물질 TMS) δ (ppm): 8.39(2H,s), 8.28(2H,s),¾ NMR (CDC1 3) standard TMS) δ (ppm): 8.39 (2H, s), 8.28 (2H, s),
7.96(2H,d), 7.84(2H,m), 7.60(2H,m), 7.10(7H,m), 6.41(2H,dd), 6.03(2H,dd), 5.82(2H,dd), 4.12(4H,m), 4.03(4H,m), 2.36(3H,s), 1.98(2H,m) 7.96 (2H, d), 7.84 (2H, m), 7.60 (2H, m), 7.10 (7H, m), 6.41 (2H, dd), 6.03 (2H, dd), 5.82 (2H, dd), 4.12 (4H, m), 4.03 (4H, m), 2.36 (3H, s), 1.98 (2H, m)
그리고, 화합물 RM-01의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 온도가 상승함에 따라 약 167°C에서 결정상의 네마틱 상으로 변화하였으며, 약 181°C를 초과할 때 등방성 액정상이 나타났다. 이러한 방식으로, 화합물 RM-이이 약 167°C 내지 181°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-01 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, the temperature was changed to a nematic phase of the crystalline phase at about 167 ° C., the isotropic liquid crystal phase appeared when it exceeds about 181 ° C. In this way, it was confirmed that compound RM- forms a nematic phase in the temperature range of about 167 ° C to 181 ° C.
실시예 8: 화합물 RM-02의 합성  Example 8: Synthesis of Compound RM-02
화합물 4-a 대신 실시예 4에 따른 화합물 4-b를 사용한 것을 제외하고, 실시예 7과 동일한 방법 및 조건으로 약 10.2g의 화합물 RM-02 (R^methyl , n=6)를 얻었다.  About 10.2 g of Compound RM-02 (R ^ methyl, n = 6) was obtained by the same method and conditions as in Example 7, except that Compound 4-b according to Example 4 was used instead of Compound 4-a.
상기 화합물 RM-02에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-02 is as follows.
XH NMR (CDC13) 표준물질 TMS) δ (ppm): 8.38(2H,s), 8.26(2H,s), 7.91(2H,d), 7.81(2H,m), 7.62(2H,m), 7.16(7H,m) , 6.44(2H,dd)', 6.05(2H,dd), 5.81(2H,dd), 4.14(4H,m), 4.06(4H,m), 2.34(3H,s), 1.71(4H,m), 1.57(4H,m), 1.29(8H,m) XH NMR (CDC1 3) Standard TMS) δ (ppm): 8.38 (2H, s), 8.26 (2H, s), 7.91 (2H, d), 7.81 (2H, m), 7.62 (2H, m), 7.16 (7H, m), 6.44 (2H, dd) ' , 6.05 (2H, dd), 5.81 (2H, dd), 4.14 (4H, m), 4.06 (4H, m), 2.34 (3H, s), 1.71 (4H, m), 1.57 (4H, m), 1.29 (8H, m)
그리고, 화합물 RM-02의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-02는 약 170°C 내지 185 °C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. 실시예 9: 화합물 RM-03의 합성 And the structure of the compound RM-02 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-02 forms a nematic phase in the temperature range of about 170 ° C to 185 ° C. Example 9: Synthesis of Compound RM-03
화합물 4-a 대신 실시예 5에 따른 화합물 4-c를 사용한 것을 제외하고, 실시예 7과 동일한 방법 및 조건으로 약 11.9g의 화합물 RM-03 (R1=ethyl , n=3)을 얻었다. About 11.9 g of Compound RM-03 (R 1 = ethyl, n = 3) was obtained by the same method and conditions as in Example 7, except that Compound 4-c according to Example 5 was used instead of Compound 4-a.
상기 화합물 RM-03에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-03 is as follows.
¾ NMR (CDCls, 표준물질 TMS) δ (ppm): 8.40(2H,s), 8.27(2H,s), 7.91(2H,d), 7.82(2H,m), 7.57(2H,m), 7.11(7H,m), 6.42(2H,dd), 6.03(2H,dd), 5.84(2H,dd), 4.11(4H,m), 4.00(4H,m), 2.53(2H,s), 1.94(2H,m), 1.24(3H,m)  ¾ NMR (CDCls, Standard TMS) δ (ppm): 8.40 (2H, s), 8.27 (2H, s), 7.91 (2H, d), 7.82 (2H, m), 7.57 (2H, m), 7.11 (7H, m), 6.42 (2H, dd), 6.03 (2H, dd), 5.84 (2H, dd), 4.11 (4H, m), 4.00 (4H, m), 2.53 (2H, s), 1.94 ( 2H, m), 1.24 (3H, m)
그리고, 화합물 RM-03의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-03은 약 148 °C 내지 161°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-03 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-03 forms a nematic phase in the temperature range of about 148 ° C to 161 ° C.
실시예 10: 화합물 RM-04의 합성  Example 10 Synthesis of Compound RM-04
화합물 4-a 대신 실시예 6에 따른 화합물 4-d를 사용한 것을 제외하고, 실시예 7과 동일한 방법 및 조건으로 약 10.3g의 화합물 RM-04 (R^ethyl , n=6)를 얻었다.  About 10.3 g of Compound RM-04 (R ^ ethyl, n = 6) was obtained by the same method and conditions as in Example 7, except that Compound 4-d according to Example 6 was used instead of Compound 4-a.
상기 화합물 RM-04에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-04 is as follows.
¾ NMR (CDC13, 표준물질 TMS) δ (ppm): 8.41(2H,s), 8.29(2H,s), 7.95(2H,d), 7.84(2H,m), 7.62(2H,m), 7.16(7H,m), 6.43(2H,dd), 6.01(2H,dd), 5.81(2H,dd), 4.14(4H,m), 4.04(4H,m), 2.58(3H,s), 1.71(4H,m), 1.54(4H,m), 1.22(8H,ra) ¾ NMR (CDC1 3 , standard TMS) δ (ppm): 8.41 (2H, s), 8.29 (2H, s), 7.95 (2H, d), 7.84 (2H, m), 7.62 (2H, m), 7.16 (7H, m), 6.43 (2H, dd), 6.01 (2H, dd), 5.81 (2H, dd), 4.14 (4H, m), 4.04 (4H, m), 2.58 (3H, s), 1.71 (4H, m), 1.54 (4H, m), 1.22 (8H, ra)
그리고, 화합물 RM-04의 조직올 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-04는 약 178°C 내지 189°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. Then, the structure of compound RM-04 was observed with a polarizing microscope and the phase transition temperature was measured. As a result, it was confirmed that compound RM-04 forms a nematic phase in the temperature range of about 178 ° C to 189 ° C.
[Scheme 2: 실시예 11 ~실시예 20]
Figure imgf000015_0001
실시 예 11: 화합물 6-a의 합성
Scheme 2: Example 11-Example 20
Figure imgf000015_0001
Example 11: Synthesis of Compound 6-a
상기 Scheme 2에서 화합물 5-a [Journal of Medicinal Chemi stry, 2008, 51, 17, 5176] 약 8g을 에탄올 약 80ml에 녹인 후, 약 9C C로 가열하였다. 여기에, 화합물 2인 6-hydroxy-2-naphthaldehyde 약 40g을 에탄을 약 150ml에 녹인 용액을 적가하였고, 약 8 시간 동안 환류 교반하였다. 반응 흔합물을 상온으로 냉각시켜 고체 생성물을 얻었고, 이를 에탄을로 여과한후 진공 건조하여 약 22g의 화합물 6-a (n=3)을 얻었다. Compound 5-a in Scheme 2 [Journal of Medicinal Chemi stry, 2008, 51, 17, 5176] After about 8g was dissolved in about 80ml of ethanol and heated to about 9C C. Here, a solution of about 40 g of 6-hydroxy-2-naphthaldehyde as a compound 2 dissolved in about 150 ml of ethane was added dropwise, followed by stirring under reflux for about 8 hours. The reaction mixture was cooled to room temperature to obtain a solid product, which was filtered through ethane and dried in vacuo to give about 22 g of compound 6-a (n = 3).
실시예 12: 화합물 6-b의 합성  Example 12: Synthesis of Compound 6-b
화합물 5-a 대신 화합물 5-b [Organic & Biomolecular Chemistry, 2008, 6, 7, 1176]올 사용한 것을 제외하고, 실시예 11과 동일한 방법 및 조건으로 약 27g의 화합물 6-b (n=6)를 얻었다. 실시예 13: 화합물 8-a의 합성  About 27 g of Compound 6-b (n = 6) by the same method and conditions as in Example 11, except that Compound 5-b [Organic & Biomolecular Chemistry, 2008, 6, 7, 1176] was used instead of Compound 5-a. Got. Example 13: Synthesis of Compound 8-a
실시예 11에 따른 화합물 6-a (n=3) 약 10g, 화합물 7_a (R2=methyl)인 2-methylterephthal ic acid [Chem. COmm. , 2011, 47, 18, 5244] 약 2.9g, 및 EDC (N-(3-dimethylaminopropyl )-N' -ethyl carbodi imide hydrochloride) 약 6.5g을 디클로로메탄에 녹인 후, 약 0°C로 냉각시켰다. 여기에 디메틸아미노피리딘 약 0.4g과 디아이소프로필에틸아민 약 8g을 첨가한 후, 약 3시간 동안 교반하였다. 상기 반웅 용액을 디클로로메탄으로 회석시킨 후, 1N 염산과 브라인으로 씻어주고 화학적으로 건조시켰다. 그리고, 여과와 감압증류를 통해 반웅물을 얻었고, 이를 컬럼 크로마토그래피로 정제하여 약 10.5g의 화합물 8-a (R2=methyl , η=3)를 얻었다. 2-methylterephthalic acid, which is about 10 g of compound 6-a (n = 3) according to Example 11, compound 7_a (R 2 = methyl) [Chem. COmm. , 2011, 47, 18, 5244] About 2.9 g, and about 6.5 g of EDC (N- (3-dimethylaminopropyl) -N'-ethyl carbodi imide hydrochloride) were dissolved in dichloromethane and cooled to about 0 ° C. About 0.4 g of dimethylaminopyridine and about 8 g of diisopropylethylamine were added thereto, followed by stirring for about 3 hours. The reaction solution was distilled with dichloromethane, washed with 1N hydrochloric acid and brine, and chemically dried. Then, a semi-ungmul was obtained through filtration and distillation under reduced pressure, which was purified by column chromatography to obtain about 10.5 g of Compound 8-a (R 2 = methyl, η = 3).
실시예 14: 화합물 8-b의 합성  Example 14 Synthesis of Compound 8-b
화합물 6-a 대신 실시예 12에 따른 화합물 6-b (n=6)를 사용한 것을 제외하고, 실시예 13과 동일한 방법 및 조건으로 약 12.4g의 화합물 8-b (R2=methyl , η=6)를 얻었다. About 12.4 g of Compound 8-b (R 2 = methyl, η = was the same method and conditions as in Example 13 except that Compound 6-b (n = 6) according to Example 12 was used instead of Compound 6-a 6) was obtained.
실시예 15: 화합물 8-c의 합성  Example 15 Synthesis of Compound 8-c
화합물 7-a 대신 화합물 7-b인 2-ethylterephthalic acid를 사용한 것을 제외하고, 실시예 13과 동일한 방법 및 조건으로 약 11.5g의 화합물 8-c (R2=ethyl , n=3)를 얻었다. About 11.5 g of Compound 8-c (R 2 = ethyl, n = 3) was obtained by the same method and conditions as in Example 13, except that 2-ethylterephthalic acid, which was Compound 7-b, was used instead of Compound 7-a.
실시예 16: 화합물 8-c의 합성 화합물 6-a 대신 실시예 12에 따른 화합물 6-b (n=6)를 사용하고, 화합물 7-a 대신 화합물 그 b인 2-ethylterephthalic acid를 사용한 것을 제외하고, 실시예 13과 동일한 방법 및 조건으로 약 10.4g의 화합물 8-d (R2=ethyl , η=6)를 얻었다. 실시예 17: 화합물 R¾H)5의 합성 Example 16: Synthesis of Compound 8-c The same method and conditions as in Example 13, except that Compound 6-b (n = 6) according to Example 12 was used instead of Compound 6-a, and 2-ethylterephthalic acid, which was Compound b, was used instead of Compound 7-a. About 10.4 g of Compound 8-d (R 2 = ethyl, η = 6) was obtained. Example 17: Synthesis of Compound R¾H) 5
실시예 13에 따른 화합물 8-a 약 10g과 PPTS (피리디늄 파라를루엔설포네이트) 약 0.4g을 테트라하이드로퓨란에 녹이고 약 2 시간 동안 환류 교반하였다. 그 후 감압증류를 통해 반웅 용액의 용매를 제거하였고, 디클로로메탄으로 희석시킨 후, 브라인으로 씻어주었다. 이로부터 얻은 유기층을 화학적으로 건조하였고, 감압증류하여 흰색 고체 화합물을 얻었다. About 10 g of compound 8-a according to Example 13 and about 0.4 g of PPTS (pyridinium paraluenesulfonate) were dissolved in tetrahydrofuran and stirred at reflux for about 2 hours. Then, the solvent was removed by distillation under reduced pressure, diluted with dichloromethane, and washed with brine. The organic layer obtained therefrom was chemically dried and distilled under reduced pressure to obtain a white solid compound.
상기 흰색 고체 화합물을 디메틸아세트아마이드 약 100ml에 녹인 후, 약 0°C로 넁각시켰다. 여기에 아크릴로일클로라이드 약 3.3g을 30분에 걸쳐 적가하였고, 상온에서 약 2시간 동안 교반하였다. 상기 반웅용액을 디에틸에테르로 희석시킨 후, 염화나트륨 수용액으로 씻어주었다. 이로부터 유기 부분을 수거하였고, 화학적으로 건조한 후, 감압 증류하여 용매를 제거하였다. 수득된 생성물을 컬럼 크로마토그래프 정제하여 약 9. 의 화합물 R -05 (R2=methyl , n=3)을 얻었다. The white solid compound was dissolved in about 100 ml of dimethylacetamide, and then cooled to about 0 ° C. About 3.3 g of acryloyl chloride was added dropwise over 30 minutes, and stirred at room temperature for about 2 hours. The semi-aqueous solution was diluted with diethyl ether and washed with an aqueous sodium chloride solution. The organic portion was collected therefrom, chemically dried, and then distilled under reduced pressure to remove the solvent. The obtained product was purified by column chromatography to obtain about 9. Compound R-05 (R 2 = methyl, n = 3).
상기 화합물 RM-05에 대한 NMR 스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-05 is as follows.
¾ NMR (CDC13, 표준물질 TMS) δ (ppm): 8.26(2H,s), 8.12(5H,m), 7.91(2H,m), 7.77(2H,m), 7.64(2H,m)( 6.99(4H,m), 6.41(2H,dd) , 6.02(2H,dd), 5.83(2H,dd), 4.11(4H,m), 3.53(4H,m) , 2.35(3H,s), 1.91(2H,m) ¾ NMR (CDC1 3 , standard TMS) δ (ppm): 8.26 (2H, s), 8.12 (5H, m), 7.91 (2H, m), 7.77 (2H, m), 7.64 (2H, m) ( 6.99 (4H, m), 6.41 (2H, dd), 6.02 (2H, dd), 5.83 (2H, dd), 4.11 (4H, m), 3.53 (4H, m), 2.35 (3H, s), 1.91 (2H, m)
그리고, 화합물 RM-05의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-05는 약 153 °C 내지 177 °C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-05 was observed by the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-05 forms a nematic phase in the temperature range of about 153 ° C to 177 ° C.
실시예 18: 화합물 R -06의 합성  Example 18 Synthesis of Compound R-06
화합물 8-a 대신 실시예 14에 따른 화합물 8-b를 사용한 것을 제외하고, 실시예 17과 동일한 방법 및 조건으로 약 lO.lg의 화합물 RM-06 (R2=methyl ( n=6)을 얻었다. Compound RM-06 of about lO.lg in the same methods and conditions as in Example 17, except that Compound 8-b according to Example 14 was used instead of Compound 8-a (R 2 = methyl ( n = 6) was obtained.
상기 화합물 RM-06에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-06 is as follows.
¾ NMR (CDCls, 표준물질 TMS) δ (ppm): 8.23(2H,s), 8.10(5H,m), 7.89(2H,m), 7.74(2H,m), 7.61(2H,m)) 6.94(4H,m), 6.38(2H,dd), 6.00(2H,dd), 5.80(2H,dd), 4.12(4H,m), 3.53(4H,m), 2.34(3H,s), 1.61(8H,m), 1.29(8H,m) ' ¾ NMR (CDCls, Standard TMS) δ (ppm): 8.23 (2H, s), 8.10 (5H, m), 7.89 (2H, m), 7.74 (2H, m), 7.61 (2H, m) ) 6.94 (4H, m), 6.38 (2H, dd), 6.00 (2H, dd), 5.80 (2H, dd), 4.12 (4H, m), 3.53 (4H, m), 2.34 (3H, s), 1.61 ( 8H, m), 1.29 (8H, m) ''
그리고, 화합물 RM-06의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-06은 약 150°C 내지 184°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-06 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-06 forms a nematic phase in the temperature range of about 150 ° C to 184 ° C.
실시예 19: 화합물 R -07의 합성  Example 19: Synthesis of Compound R-07
화합물 8-a 대신 실시예 15에 따른 화합물 8-c를 사용한 것을 제외하고, 실시예 17과 동일한 방법 및 조건으로 약 9.8g의 화합물 RM-07 (R2=ethyl , n=3)을 얻었다. About 9.8 g of Compound RM-07 (R 2 = ethyl, n = 3) was obtained by the same method and conditions as in Example 17, except that Compound 8-c according to Example 15 was used instead of Compound 8-a.
상기 화합물 RM-07에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-07 is as follows.
¾ NMR (CDC13) 표준물질 TMS) δ (ppm): 8.25(2H,s), 8.10(5H,m),¾ NMR (CDC1 3) standard TMS) δ (ppm): 8.25 (2H, s), 8.10 (5H, m),
7.91(2H,m), 7.74(2H,ra), 7.61(2H,m), 7.01(4H,m), 6.42(2H,dd), 6.01(2H,dd), 5.86(2H,dd), 4.14(4H,m), 3.51(4H,m), 2.54(5H,s), 1.94(2H,m), 1.21(3H,m) 7.91 (2H, m), 7.74 (2H, ra), 7.61 (2H, m), 7.01 (4H, m), 6.42 (2H, dd), 6.01 (2H, dd), 5.86 (2H, dd), 4.14 (4H, m), 3.51 (4H, m), 2.54 (5H, s), 1.94 (2H, m), 1.21 (3H, m)
그리고, 화합물 RM-07의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-07은 약 164°C 내지 180°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-07 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-07 forms a nematic phase in the temperature range of about 164 ° C to 180 ° C.
실시예 20: 화합물 R -08의 합성  Example 20 Synthesis of Compound R-08
화합물 8-a 대신 실시예 16에 따른 화합물 8-d를 사용한 것을 제외하고, 실시예 17과 동일한 방법 및 조건으로 약 ll.Og의 화합물 RM-08 (R2=ethyl , n=6)을 얻었다. About ll.Og of compound RM-08 (R 2 = ethyl, n = 6) was obtained by the same method and conditions as in Example 17, except that Compound 8-d according to Example 16 was used instead of Compound 8-a. .
상기 화합물 RM-08에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-08 is as follows.
¾ NMR (CDCls, 표준물질 TMS) δ (ppm): 8.26(2H,s), 8.12(5H,m), 7.89(2H,m), 7.75(2H,m), 7.64(2H,m), 6.95(4H,m), 6.38(2H,dd) , 6.01(2H,dd), 5.81(2H,dd), 4.15(4H,m), 3.53(4H,m), 2.53(2H,s), 1.62(8H,m), 1.28(8H,m), 1.20(3H,m) 그리고, 화합물 RM-08의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다 . 그 결과, 화합물 RM-08은 약 178 °C 내지 202 °C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되 었다 . ¾ NMR (CDCls, Standard TMS) δ (ppm): 8.26 (2H, s), 8.12 (5H, m), 7.89 (2H, m), 7.75 (2H, m), 7.64 (2H, m), 6.95 (4H, m), 6.38 (2H, dd), 6.01 (2H, dd), 5.81 (2H, dd), 4.15 (4H, m), 3.53 (4H, m), 2.53 (2H, s), 1.62 ( 8H, m), 1.28 (8H, m), 1.20 (3H, m) And the structure of the compound RM-08 was observed with a polarizing microscope and the phase transition temperature was measured. As a result, it was confirmed that compound RM-08 forms a nematic phase in the temperature range of about 178 ° C to 202 ° C.
[Scheme 3: 비교예 1 ~ 비교예 6] [Scheme 3: Comparative Example 1 to Comparative Example 6]
Figure imgf000019_0001
Figure imgf000019_0001
비교예 1: 화합물 10-a의 합성 Comparative Example 1: Synthesis of Compound 10-a
상기 Scheme 3에서 화합물 9인 methyl 6-hydroxy-2-naphthoat e 약 100g, 3-클로로프로판올 약 94g, 및 포타슘 카보네이트 약 182g을 아세톤에 녹인 후, 약 24 시 간 동안 환류 교반하였다 . 반응 흔합물을 상온으로 냉각한 후, 여과하여 고체를 제거하고 감압 증류하였다 . 그리고, 컬럼 크로마토그래프 정제를 통해 약 13¾의 화합물 10-a (n=3)를 얻었다 . About 100 g of methyl 6-hydroxy-2-naphthoate, compound 9 of Scheme 3, about 94 g of 3-chloropropanol, and about 182 g of potassium carbonate were added to acetone. After melting, the mixture was stirred under reflux for about 24 hours. The reaction mixture was cooled to room temperature, filtered to remove solids and distilled under reduced pressure. Then, about 13¾ of compound 10-a (n = 3) was obtained by column chromatography.
비교예 2: 화합물 10-b의 합성  Comparative Example 2: Synthesis of Compound 10-b
3-클로로프로판올 대신 6-클로로핵산올을 사용한 것을 제외하고, 비교예 1과 동일한 방법 및 조건으로 약 110g의 화합물 10-b (n=6)를 얻었다 . 비교예 3: 화합물 11-a의 합성  About 110 g of Compound 10-b (n = 6) was obtained by the same method and conditions as in Comparative Example 1, except that 6-chloronucleol was used instead of 3-chloropropanol. Comparative Example 3: Synthesis of Compound 11-a
비교예 1에 따른 화합물 10-a 약 120g과 PPTS (피 리디늄 파라를루엔설포네이트) 약 21g을 디클로로메탄에 녹인 후, 약 0°C로 넁각시켰다 . 여기에 3 ,4-dihydro_2H-pyran 약 42g을 디클로로메탄에 녹여서 적가한 후, 약 12시간 동안 교반하였다 . 그리고, 상기 반웅용액을 브라인으로 세척하고 화학적으로 건조시 킨 후, 감압증류하여 약 145g의 화합물 11-a (n=3)를 얻었다 . About 120 g of compound 10-a according to Comparative Example 1 and about 21 g of PPTS (pyridinium paraluenesulfonate) were dissolved in dichloromethane, and then cooled to about 0 ° C. About 42 g of 3,4-dihydro_2H-pyran was dissolved in dichloromethane and added dropwise thereto, followed by stirring for about 12 hours. Then, the semi-aqueous solution was washed with brine and chemically dried, followed by distillation under reduced pressure to obtain about 145 g of compound 11-a (n = 3).
비교예 4: 화합물 11-b의 합성  Comparative Example 4: Synthesis of Compound 11-b
화합물 10-a 대신 비교예 2에 따른 화합물 10-b를 사용한 것을 제외하고, 비교예 3과 동일한 방법 및 조건으로 약 110g의 화합물 11-b (n=6)를 얻었다. 비교예 5: 화합물 12-a의 합성  About 110 g of Compound 11-b (n = 6) was obtained by the same method and conditions as the Comparative Example 3, except that Compound 10-b according to Comparative Example 2 was used instead of Compound 10-a. Comparative Example 5: Synthesis of Compound 12-a
비교예 3에 따른 화합물 11-a 약 140g을 메탄을에 녹인 후, 소듐하이드록사이드 (2M, 300ml )를 첨가하였고, 약 2시간 동안 환류 교반하였고, 감입 증류하였다 . 상기 반응물을 물과 디클로로메탄에 녹인 후 , 3M 염산을 사용하여 pH를 5로 조절하였다 . 이로부터 유기층을 분리하여 화학적으로 건조한 후 감압증류하였고, 핵산으로 씻어 약 107g의 흰색 고체인 화합물 12— a (n=3)를 얻었다 .  About 140 g of Compound 11-a according to Comparative Example 3 was dissolved in methane, and sodium hydroxide (2M, 300 ml) was added thereto, and the mixture was stirred under reflux for about 2 hours and distilled under reduced pressure. After dissolving the reaction in water and dichloromethane, the pH was adjusted to 5 using 3M hydrochloric acid. The organic layer was separated, chemically dried, distilled under reduced pressure, and washed with nucleic acid to obtain compound 12-a (n = 3) as a white solid.
비교예 6: 화합물 12-b의 합성  Comparative Example 6: Synthesis of Compound 12-b
화합물 11-a 대신 비교예 4에 따른 화합물 11-b를 사용한 것을 제외하고 , 비교예 5와 동일한 방법 및 조건으로 약 89g의 화합물 12-b (n=6)를 얻었다 . About 89 g of Compound 12-b by the same methods and conditions as Comparative Example 5, except that Compound 11-b according to Comparative Example 4 was used instead of Compound 11-a (n = 6) was obtained.
[Scheme 4: 비교예 7 비교예 Scheme 4: Comparative Example 7 Comparative Example
Figure imgf000021_0001
비교예 7: 화합물 14-a의 합성 비교예 5에 따른 화합물 12-a 약 12. lg, 화합물 13인 hydroquinone 약 3g, 및 EDC (N-(3-dimethylaminopropyl)-N'-ethylcar bodi imide hydrochloride) 약 7.2g을 디클로로메탄에 녹인 후 약 0°C로 냉각시켰다. 여기에 디메틸아미노피리딘 약 0.9g과 디아이소프로필에틸아민 약 9g을 첨가하고, 약 3시간 동안 교반하였다. 상기 반웅 용액을 디클로로메탄으로 희석시킨 후, 1N 염산과 브라인으로 씻어주고 화학적으로 건조시켰다. 그리고, 여과와 감압증류를 통해 반웅물을 얻었고, 이를 컬럼 크로마토그래피로 정제하여 약 10.5g의 화합물 14-a (n=3)를 얻었다.
Figure imgf000021_0001
Comparative Example 7: Synthesis of Compound 14-a Compound 12-a according to Comparative Example 5, about 12. lg, about 13 g of hydroquinone as compound 13, and about 7.2 g of EDC (N- (3-dimethylaminopropyl) -N'-ethylcarbodi imide hydrochloride) were dissolved in dichloromethane. Cooled to 0 ° C. About 0.9 g of dimethylaminopyridine and about 9 g of diisopropylethylamine were added thereto, followed by stirring for about 3 hours. The reaction solution was diluted with dichloromethane, washed with 1N hydrochloric acid and brine, and chemically dried. Then, a semi-ungmul was obtained through filtration and distillation under reduced pressure, which was purified by column chromatography to obtain about 10.5 g of Compound 14-a (n = 3).
비교예 8: 화합물 14-b의 합성  Comparative Example 8: Synthesis of Compound 14-b
화합물 12-a 대신 비교예 6에 따른 화합물 12-b를 사용한 것을 제외하고, 비교예 7과 동일한 방법 및 조건으로 약 11.5g의 화합물 14-b (n=6)를 얻었다. 비교예 9: 화합물 RM-09의 합성  About 11.5 g of Compound 14-b (n = 6) was obtained by the same method and conditions as the Comparative Example 7, except that Compound 12-b according to Comparative Example 6 was used instead of Compound 12-a. Comparative Example 9: Synthesis of Compound RM-09
비교예 7에 따른 화합물 14-a 약 10g과 PPTS (피리디늄 파라를루엔설포네이트) 약 0.4g을 테트라하이드로퓨란에 녹이고 약 2 시간 동안 환류 교반하였다. 그 후 감압증류를 통해 반웅 용액의 용매를 제거하였고, 디클로로메탄으로 희석시킨 후, 브라인으로 씻어주었다. 이로부터 얻은 유기층을 화학적으로 건조하였고, 감압증류하여 흰색 고체 화합물을 얻었다.  About 10 g of compound 14-a according to Comparative Example 7 and about 0.4 g of PPTS (pyridinium paraluenesulfonate) were dissolved in tetrahydrofuran and stirred at reflux for about 2 hours. Then, the solvent was removed by distillation under reduced pressure, diluted with dichloromethane, and washed with brine. The organic layer obtained therefrom was chemically dried and distilled under reduced pressure to obtain a white solid compound.
상기 흰색 고체 화합물을 디메틸아세트아마이드 약 90ml에 녹인 후, 약 0°C로 넁각시켰다. 여기에 아크릴로일클로라이드 약 7g을 30분에 걸쳐 적가하였고, 상온에서 약 2시간 동안 교반하였다. 상기 반웅용액을 디에틸에테르로 희석시킨 후, 염화나트륨 수용액으로 씻어주었다. 이로부터 유기 부분을 수거하였고, 화학적으로 건조한 후, 감압 증류하여 용매를 제거하였다. 수득된 생성물을 컬럼 크로마토그래프 정제하여 약 12.0g의 화합물 RM-09 (n=3)를 얻었다. The white solid compound was dissolved in about 90 ml of dimethylacetamide, and then cooled to about 0 ° C. About 7 g of acryloyl chloride was added dropwise over 30 minutes, and stirred at room temperature for about 2 hours. The reaction solution was diluted with diethyl ether and washed with an aqueous sodium chloride solution. The organic portion was collected therefrom, chemically dried, and then distilled under reduced pressure to remove the solvent. The obtained product was column chromatograph purified to give about 12.0 g of compound RM-09 (n = 3).
상기 화합물 RM-09에 대한 NMR 스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-09 is as follows.
¾ 醒 (CDCl3l 표준물질 TMS) δ (ppm): 8.52(2H,s), 8.20(2H,d), 7.75(2H,d), 7.60(2H,d), 7.22(4H,s), 7.02(4H,m), 6.44(2H,dd), 6.09(2H,dd), 5.90(2H,dd), 4.04(4H,ra), 3.95(4H,m) , 1.99(4H,m) ¾ CD (CDCl 3l standard TMS) δ (ppm): 8.52 (2H, s), 8.20 (2H, d), 7.75 (2H, d), 7.60 (2H, d), 7.22 (4H, s), 7.02 (4H, m), 6.44 (2H, dd), 6.09 (2H, dd), 5.90 (2H, dd), 4.04 (4H, ra), 3.95 (4H, m), 1.99 (4H, m)
그리고, 화합물 RM-09의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-09는 약 190°C 내지 205°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-09 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-09 forms a nematic phase in the temperature range of about 190 ° C to 205 ° C.
비교예 10: 화합물 R -10의 합성  Comparative Example 10 Synthesis of Compound R-10
화합물 14-a 대신 비교예 8에 따른 화합물 14-b를 사용한 것을 제외하고, 비교예 9와 동일한 방법 및 조건으로 약 ll.lg의 화합물 RM-10 (n=6)을 얻었다.  About ll.lg Compound RM-10 (n = 6) was obtained by the same method and conditions as the Comparative Example 9, except that Compound 14-b according to Comparative Example 8 was used instead of Compound 14-a.
상기 화합물 RM-10에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-10 is as follows.
¾ NMR (CDCls, 표준물질 TMS) δ (ppm): 8.50(2H,s), 8.19(2H,d), ¾ NMR (CDCls, standard TMS) δ (ppm): 8.50 (2H, s), 8.19 (2H, d),
7.73(2H,d), 7.62(2H,d), 7.24(4H,s), 7.00(4H,m), 6.45(2H,dd), 6.07(2H,dd), 5.91(2H,dd), 4.14(4H,m), 4.04(4H,m), 1.75(4H,m) , 1.51(4H,m), 1.29(8H,m) 7.73 (2H, d), 7.62 (2H, d), 7.24 (4H, s), 7.00 (4H, m), 6.45 (2H, dd), 6.07 (2H, dd), 5.91 (2H, dd), 4.14 (4H, m), 4.04 (4H, m), 1.75 (4H, m), 1.51 (4H, m), 1.29 (8H, m)
그리고, 화합물 RM-10의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-10은 약 201°C 내지 212°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-10 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-10 forms a nematic phase in the temperature range of about 201 ° C to 212 ° C.
[Scheme 5: 비교예 11 ~ 비교예 13] Scheme 5: Comparative Example 11 to Comparative Example 13
Figure imgf000024_0001
비교예 n: 화합물 16의 합성
Figure imgf000024_0001
Comparative Example n: Synthesis of Compound 16
화합물 2 대신 화합물 15인 4-hydr oxybenza ldehyde를 사용한 것을 제외하고, 실시 예 1과 동일한 방법 및 조건으로 약 22g의 화합물 16을 얻었다 .  About 22 g of Compound 16 was obtained by the same method and conditions as in Example 1, except that 4-hydr oxybenza ldehyde, which was Compound 15, was used instead of Compound 2.
비교예 12: 화합물 17의 합성  Comparative Example 12: Synthesis of Compound 17
화합물 3-a 대신 비교예 11에 따른 화합물 16을 사용한 것을 제외하고, 실시 예 3과 동일한 방법 및 조건으로 약 15.3g의 화합물 17을 얻었다. About 15.3 g of Compound 17 was prepared by the same method and conditions as in Example 3, except that Compound 16 according to Comparative Example 11 was used instead of Compound 3-a. Got it.
비교예 13: 화합물 R -11의 합성  Comparative Example 13: Synthesis of Compound R-11
화합물 4-a 대신 비교예 12에 따른 화합물 17을 사용한 것을 제외하고, 실시예 7 동일한 방법 및 조건으로 약 12g의 화합물 RM-11을 얻었다.  Example 7 About 12 g of Compound RM-11 was obtained by the same method and conditions as in Example 7, except that Compound 17 according to Comparative Example 12 was used instead of Compound 4-a.
상기 화합물 RM-11에 대한 NMR 스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-11 is as follows.
¾ 賺 (CDC13, 표준물질 TMS) δ (ppm): 8.39(2H,s), 7.85(4H,m), 7.30(2H,m), 7.06(4H,m), 6.46(lH,d), 6.27(2H,dd), 6.05(2H,dd), 5.59(2H,dd), 4.20(8H,m), 2.36(3H,s), 2.10(4H,m) ¾ C (CDC1 3 , standard TMS) δ (ppm): 8.39 (2H, s), 7.85 (4H, m), 7.30 (2H, m), 7.06 (4H, m), 6.46 (lH, d), 6.27 (2H, dd), 6.05 (2H, dd), 5.59 (2H, dd), 4.20 (8H, m), 2.36 (3H, s), 2.10 (4H, m)
그리고, 화합물 RM-11의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-11은 약 103°C 내지 132°C의 온도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. And the structure of the compound RM-11 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-11 forms a nematic phase in the temperature range of about 103 ° C to 132 ° C.
[Scheme 6: 비교예 14 ~비교예 15] Scheme 6: Comparative Example 14-Comparative Example 15
Figure imgf000026_0001
Figure imgf000026_0001
비교예 14: 화합물 19와합성  Comparative Example 14 Synthesis with Compound 19
화합물 13 대신 화합물 18인 2-methylbenzene-l,4-di 을 사용한 것을 제외하고, 비교예 7과 동일한 방법 및 조건으로 약 15g의 화합물 19를 얻었다.  About 15 g of Compound 19 was obtained by the same method and conditions as in Comparative Example 7, except that 2-methylbenzene-l, 4-di, which was Compound 18, was used instead of Compound 13.
비교예 15: 화합물 RM-12의 합성  Comparative Example 15 Synthesis of Compound RM-12
화합물 14-a 대신 비교예 14에 따른 화합물 19를 사용한 것을 제외하고, 비교예 9와 동일한 방법 및 조건으로 약 9g의 화합물 RM-12를 얻었다. About 9 g of Compound RM-12 was obtained by the same method and conditions as the Comparative Example 9, except that Compound 19 according to Comparative Example 14 was used instead of Compound 14-a. Got it.
상기 화합물 RM-12에 대한 NMR스펙트럼은 다음과 같다.  The NMR spectrum of the compound RM-12 is as follows.
:H NMR (CDCI3, 표준물질 TMS) δ (ppm): 8.64(2H,s), 8.32(2H,d), 7.92(4H,d), 7.88(4H,d), 7.42(3H,m), 6.43(2H,dd) , 6.04(2H,dd), 5.92(2H,dd), 4.16(4H,m), 4.03(4H,m), 2.15(3H,s), 1.75(4H,m), 1.49(4H,m), 1.29(8H,m) : H NMR (CDCI3, Standard TMS) δ (ppm): 8.64 (2H, s), 8.32 (2H, d), 7.92 (4H, d), 7.88 (4H, d), 7.42 (3H, m), 6.43 (2H, dd), 6.04 (2H, dd), 5.92 (2H, dd), 4.16 (4H, m), 4.03 (4H, m), 2.15 (3H, s), 1.75 (4H, m), 1.49 (4H, m), 1.29 (8H, m)
그리고, 화합물 RM-12의 조직을 편광현미경으로 관찰하고 상전이온도를 측정하였다. 그 결과, 화합물 RM-12는 약 198°C 내지 210°C의 은도 범위에서 네마틱 상을 형성한다는 것이 확인되었다. 제조예 1~8 (위상차필름의 제조) And the structure of the compound RM-12 was observed with the polarizing microscope, and the phase transition temperature was measured. As a result, it was confirmed that compound RM-12 forms a nematic phase in the silver range of about 198 ° C to 210 ° C. Preparation Examples 1 to 8 (Manufacture of Retardation Film)
전체 조성물 100 중량부를 기준으로, 상기 화합물 RM-01 25 중량부, 광개시제로 Irgacure 907(스위스의 Ciba-Geigy사 제조) 5 중량부, CPO(cyclopentanone) 잔부를 포함하는 중합성 액정 조성물을 제조하였다. 상기 액정 조성물을 를 코팅 방법으로 노보넨계 광 배향물질이 코팅된 COP (시클로을레핀폴리머) 필름 위에 코팅한 후, 약 90°C로 2분 동안 건조하여 액정 화합물이 배향되도록 하였다. 그 후, 상기 필름에 200mW/ciif의 고압 수은등을 광원으로 하는 비편광 UV를 조사하여 액정의 배향 상태를 고정시켜 위상차 필름을 제조하였다. Based on 100 parts by weight of the total composition, 25 parts by weight of the compound RM-01, 5 parts by weight of Irgacure 907 (manufactured by Ciba-Geigy, Switzerland) as a photoinitiator, and a polymerizable liquid crystal composition including a balance of CPO (cyclopentanone) was prepared. The liquid crystal composition was coated on a norbornene-based photoalignment material-coated COP (cycloolefin polymer) film by a coating method, and then dried at about 90 ° C. for 2 minutes to align the liquid crystal compound. Thereafter, the film was irradiated with non-polarized UV light having a high pressure mercury lamp of 200 mW / ciif as a light source to fix the alignment state of the liquid crystal to prepare a retardation film.
상기와 같은 방법으로, 화합물 RM-01 대신 화합물 RM-02 내지 RM-08 중 어느 하나를 포함하는 조성물을 제조하였고, 이를 사용하여 위상차 필름을 각각 제조하였다.  In the same manner as described above, a composition including any one of compounds RM-02 to RM-08 instead of compound RM-01 was prepared, and retardation films were prepared, respectively.
비교 제조예 1~4 (위상차 필름의 제조)  Comparative Production Examples 1 to 4 (Production of Phase Difference Film)
화합물 RM-01 대신 비교예들에 따른 화합물 RM-09, RM-10, RM-11, 또는 RM-12를 사용한 것을 제외하고, 제조예 1~8과 동일한 방법으로 위상차 필름을 각각 제조하였다.  Retardation films were prepared in the same manner as in Preparation Examples 1 to 8, except that Compound RM-09, RM-10, RM-11, or RM-12 according to Comparative Examples was used instead of Compound RM-01.
참고예  Reference Example
화합물 RM-01 대신 하기 화학식 10으로 표시되는 중합성 액정 화합물 (RM 257, 제조사: ΧΓΑΝ RUILIAN MODERN Co. , Ltd)을 사용한 것을 제외하고, 제조예 1~8과 동일한 방법으로 위상차 필름을 제조하였다. [화학식 10]
Figure imgf000028_0001
A retardation film was manufactured in the same manner as in Preparation Examples 1 to 8, except that the polymerizable liquid crystal compound (RM 257, manufactured by ΧΓΑΝ RUILIAN MODERN Co., Ltd) was used instead of the compound RM-01. [Formula 10]
Figure imgf000028_0001
시험예 1 Test Example 1
제조예 1~8, 비교 제조예 1~4 및 참고예에 따른 각각의 위상차 필름에 대하여, 정량적인 위상차 값을 Axoscan(Axomatrix사 제조)을 이용하여 측정하였다. 이때 독립적으로 두께를 측정하고, 수득된 값으로부터 Δη 값을 구했으며, 그 결과를 하기 표 1에 나타내었다.  For each retardation film according to Production Examples 1 to 8, Comparative Production Examples 1 to 4, and Reference Example, the quantitative phase difference value was measured using Axoscan (manufactured by Axomatrix). In this case, the thicknesses were measured independently, Δη values were obtained from the obtained values, and the results are shown in Table 1 below.
시험예 2  Test Example 2
직교 상태로 배치된 편광판 사이에 제조예 1~8, 비교 제조예 1-4 및 참고예에 따른 각각의 위상차 필름을 배치한 다음, ECLIPSE LV100P0L (NIKON사 제조)을 이용하여 촬영하는 방법으로 빛샘 정도를 확인하였다. 촬영 결과는 각 화합물별로 도 1 및 도 2에 나타내었다.  Between the polarizing plates arranged in an orthogonal state, each retardation film according to Production Examples 1 to 8, Comparative Production Examples 1-4 and Reference Example was placed, and then light leakage was obtained by using ECLIPSE LV100P0L (manufactured by Nikon). It was confirmed. The photographing results are shown in FIGS. 1 and 2 for each compound.
【표 1】 Table 1
Figure imgf000028_0002
상기 표 1을 통해 알 수 있는 바와 같이, 상기 표 1을 통해 알 수 있는 바와 같이, 상기 화합물 RM— 09, RM-10, 또는 RM-12를 포함하는 위상차 필름의 경우, 제조 과정에서 화합물의 배향이 고르지 않아 정확한 복굴절율을 측정할 수 없었다. 또한, 주쇄에 이민 연결기를 포함하지만 나프탈렌환을 포함하지 않는 화합물 RM-11의 경우 배향성은 양호하였으나, 복굴절율이 화합물 RM257과 유사한수준으로 낮게 나타났다. 그에 비하여, 제조예 1~8에 따른 화합물 RM-01 내지 RM-08을 포함하는 위상차 필름은 기존의 필름보다 상대적으로 높은 복굴절율을 가지는 것으로 확인되 었다.
Figure imgf000028_0002
As can be seen from Table 1, as can be seen from Table 1, in the case of a retardation film containing the compound RM— 09, RM-10, or RM-12, the orientation of the compound in the manufacturing process The irregular birefringence could not be measured. In addition, the compound RM-11 including the imine linkage group in the main chain but not the naphthalene ring had good orientation, but the birefringence was similar to that of the compound RM257. In contrast, it was confirmed that the retardation film including the compounds RM-01 to RM-08 according to Preparation Examples 1 to 8 has a relatively higher birefringence than the conventional film.
나아가, 도 1 및 도 2를 통해 알 수 있는 바와 같이, 제조예 1~8에 따른 화합물 RM-01 내지 RM-08을 포함하는 위상차 필름은 비교 제조예 1~4 및 참고예의 필름에 비하여 빛샘 현상도 거의 나타나지 않는 것으로 확인되 었다 .  Furthermore, as can be seen from FIGS. 1 and 2, the retardation film including the compounds RM-01 to RM-08 according to Preparation Examples 1 to 8 has a light leakage phenomenon compared to the films of Comparative Preparation Examples 1 to 4 and Reference Examples. It was confirmed that almost did not appear either.

Claims

【특허청구범위】 [Patent Claims]
【청구항 1】  [Claim 1]
하기 화학식 1로 표시되는 중합성 액정 화합물:  A polymerizable liquid crystal compound represented by the following formula (1):
[화학식 1]  [Formula 1]
Figure imgf000030_0001
상기 화학식 1에서,
Figure imgf000030_0001
In Chemical Formula 1,
A는 탄소수 1 내지 10의 알킬기이고;  A is an alkyl group having 1 to 10 carbon atoms;
D1, D2, G1 및 G2는 각각 독립적으로 단일 결합 또는 2가의 연결기로서, 상기 D1, D2ᅳ G1 및 G2 중 적어도 하나는 이민기이고; D 1 , D 2 , G 1 and G 2 are each independently a single bond or a divalent linking group, wherein at least one of D 1 , D 2 ᅳ G 1 and G 2 is an imine group;
E1 및 E2는 각각 독립적으로 벤젠환 또는 나프탈렌환으로서, 상기 E1 및 E2 중 적어도 하나는 나프탈렌환이고; E 1 and E 2 are each independently a benzene ring or a naphthalene ring, and at least one of E 1 and E 2 is a naphthalene ring;
J1 및 J2는 각각 독립적으로 탄수소 1 내지 10의 알킬렌기이고; J 1 and J 2 are each independently an alkylene group of 1 to 10 carbohydrates;
L1 및 L2는 각각 독립적으로 수소 또는 중합성기이다. 【청구항 2】 L 1 and L 2 are each independently hydrogen or a polymerizable group. [Claim 2]
제 1 항에 있어서,  The method of claim 1,
8.0 ppm 내지 8.5 ppm의 δ에서 적어도 하나의 피크를 갖는 ¾ NMR 스펙트럼을 나타내는 중합성 액정 화합물. 【청구항 3】 - 제 1 항에 있어서,  A polymerizable liquid crystal compound having a ¾ NMR spectrum having at least one peak at δ of 8.0 ppm to 8.5 ppm. Claim 3-The method of claim 1,
상기 D1, D2, G1 및 G2는 각각 독립적으로 단일결합, -CH=N -, -0-, - S -, -CO—, -C00-, -0C0-, -0-C00-, -C0-NR-, -NR-C0-, -NR-C0-NR-, -0CH2-, -CH20-, -SCH-, -C¾S -, -CF20-, -0CF2-( -CF2S-, -SCF2-, -CH2CH2-, -(CH2)3-, -(CH2)4-, -CF2CH2-, -CH2CF2-, -CF2CF2-, -C=C- 또는 -C≡C- 이고, 상기 R은 각각 독립적으로 수소 또는 탄소수 1 내지 10의 알킬기이며; D 1 , D 2 , G 1 and G 2 are each independently a single bond, -CH = N-, -0-, -S-, -CO—, -C00-, -0C0-, -0-C00- , -C0-NR-, -NR-C0-, -NR-C0-NR-, -0CH 2- , -CH 2 0-, -SCH-, -C¾S-, -CF 2 0-, -0CF 2- ( -CF 2 S-, -SCF 2- , -CH 2 CH 2 -,-(CH 2 ) 3 -,-(CH 2 ) 4- , -CF 2 CH 2- , -CH 2 CF 2 -,- CF 2 CF 2 —, —C═C— or —C≡C—, wherein each R is independently hydrogen or an alkyl group having 1 to 10 carbon atoms;
상기 D1, D2, G1 및 G2 중 적어도 하나는 이민기 (-CH=N-)인 중합성 액정 화합물 . At least one of D 1 , D 2 , G 1, and G 2 is an imine group (—CH = N—) Liquid crystal compound.
【청구항 4】 [Claim 4]
제 1 항에 있어서,  The method of claim 1,
상기 E1 및 E2는 각각 나프탈렌환인 중합성 액정 화합물 . The polymerizable liquid crystal compound wherein E 1 and E 2 are each a naphthalene ring.
【청구항 5】 [Claim 5]
제 1 항에 있어서,  The method of claim 1,
상기 L1 및 L2는 각각 독립적으로 수소기, 아크릴레이트기, 메타크릴레이트기 또는 에폭시기 인 중합성 액정 화합물 . The L 1 and L 2 are each independently a hydrogen group, an acrylate group, a methacrylate group or an epoxy group.
【청구항 6】 [Claim 6]
제 1 항에 따른 화합물을 포함하는 중합성 액정 조성물 . 【청구항 7】  A polymerizable liquid crystal composition comprising the compound according to claim 1. [Claim 7]
제 6 항에 있어서,  The method of claim 6,
중합 개시제 및 용매를 더 포함하는 중합성 액정 조성물 . 【청구항 8]  A polymerizable liquid crystal composition further comprising a polymerization initiator and a solvent. [Claim 8]
제 1 항에 따른 화학식 1의 중합성 액정 화합물의 경화물 또는 중합체를 포함하는 광학 이방체 .  An optically anisotropic body comprising a cured product or a polymer of the polymerizable liquid crystal compound according to claim 1.
【청구항 9】 [Claim 9]
제 8 항에 있어서,  The method of claim 8,
상기 화학식 1의 중합성 액정 화합물의 말단 중합성기의 적어도 일부가 부가 중합 또는 가교되어 있는 경화물 또는 중합체를 포함하는 광학 이방체 .  An optically anisotropic body comprising a cured product or a polymer in which at least a part of the terminal polymerizable group of the polymerizable liquid crystal compound of Formula 1 is polymerized or crosslinked.
【청구항 10】 [Claim 10]
제 8 항에 따른 광학 이 방체를 포함하는 액정 표시장치용 광학 소자 .  An optical element for a liquid crystal display device comprising the optical barrier according to claim 8.
PCT/KR2013/005608 2012-06-28 2013-06-25 Polymerizable liquid crystal compound, and liquid crystal composition and optically anisotropic body comprising same WO2014003416A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201380028069.9A CN104379699B (en) 2012-06-28 2013-06-25 Can poly-liquid-crystal compounds, the liquid-crystal composition comprising this compound and optically anisotropic body
JP2015520011A JP6042538B2 (en) 2012-06-28 2013-06-25 Polymerizable liquid crystal compound, liquid crystal composition containing the same, and optical anisotropic body
US14/355,898 US9127104B2 (en) 2012-06-28 2013-06-25 Polymerizable liquid crystal compound, a liquid crystal composition comprising the compound, and an optically anisotropic body

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20120070200 2012-06-28
KR10-2012-0070200 2012-06-28
KR1020130072986A KR101502488B1 (en) 2012-06-28 2013-06-25 Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
KR10-2013-0072986 2013-06-25

Publications (1)

Publication Number Publication Date
WO2014003416A1 true WO2014003416A1 (en) 2014-01-03

Family

ID=49783481

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/005608 WO2014003416A1 (en) 2012-06-28 2013-06-25 Polymerizable liquid crystal compound, and liquid crystal composition and optically anisotropic body comprising same

Country Status (1)

Country Link
WO (1) WO2014003416A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016056584A1 (en) * 2014-10-08 2016-04-14 日産化学工業株式会社 Composition for production of liquid crystal alignment film for in-plane switching liquid crystal display element, liquid crystal alignment film using same, production method therefor, liquid crystal display element having liquid crystal alignment film, and production method therefor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090041385A (en) * 2006-07-10 2009-04-28 가부시키가이샤 아데카 Polymerizable composition
KR20100014882A (en) * 2007-03-01 2010-02-11 제온 코포레이션 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic substance
KR20100126182A (en) * 2009-05-22 2010-12-01 칫소가부시키가이샤 Optical anisotropic material
KR20110040789A (en) * 2008-06-30 2011-04-20 제온 코포레이션 Polymerizable liquid crystal compounds, polymerizable liquid crystal compositions, liquid crystal polymers and optically anisotropic materials
KR101136495B1 (en) * 2004-05-31 2012-04-19 디아이씨 가부시끼가이샤 Polymerizable liquid crystal composition and optically anisotropic body

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101136495B1 (en) * 2004-05-31 2012-04-19 디아이씨 가부시끼가이샤 Polymerizable liquid crystal composition and optically anisotropic body
KR20090041385A (en) * 2006-07-10 2009-04-28 가부시키가이샤 아데카 Polymerizable composition
KR20100014882A (en) * 2007-03-01 2010-02-11 제온 코포레이션 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic substance
KR20110040789A (en) * 2008-06-30 2011-04-20 제온 코포레이션 Polymerizable liquid crystal compounds, polymerizable liquid crystal compositions, liquid crystal polymers and optically anisotropic materials
KR20100126182A (en) * 2009-05-22 2010-12-01 칫소가부시키가이샤 Optical anisotropic material

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016056584A1 (en) * 2014-10-08 2016-04-14 日産化学工業株式会社 Composition for production of liquid crystal alignment film for in-plane switching liquid crystal display element, liquid crystal alignment film using same, production method therefor, liquid crystal display element having liquid crystal alignment film, and production method therefor
KR20170065605A (en) * 2014-10-08 2017-06-13 닛산 가가쿠 고교 가부시키 가이샤 Composition for production of liquid crystal alignment film for in-plane switching liquid crystal display element, liquid crystal alignment film using same, production method therefor, liquid crystal display element having liquid crystal alignment film, and production method therefor
CN107003577A (en) * 2014-10-08 2017-08-01 日产化学工业株式会社 The driving liquid crystal of transverse electric field represents that element is manufactured with composition with liquid crystal orientation film, used the liquid crystal orientation film and its manufacture method of said composition and the liquid crystal with liquid crystal orientation film to represent element and its manufacture method
CN107003577B (en) * 2014-10-08 2021-06-25 日产化学工业株式会社 Composition for producing liquid crystal alignment film, liquid crystal alignment film using same, liquid crystal display element, and method for producing same
KR102448661B1 (en) 2014-10-08 2022-09-28 닛산 가가쿠 가부시키가이샤 Composition for production of liquid crystal alignment film for in-plane switching liquid crystal display element, liquid crystal alignment film using same, production method therefor, liquid crystal display element having liquid crystal alignment film, and production method therefor

Similar Documents

Publication Publication Date Title
JP6896614B2 (en) Liquid crystal medium with homeotropic orientation
KR100670983B1 (en) Polymerizable compound, polymerizable liquid crystal composition containing the compound, and optical anisotropic body
CN108698973B (en) Polymerizable compound and liquid crystal composition using same
KR101502488B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
JP6358400B2 (en) Polymer for photo-alignment film, polymer solution, photo-alignment film, optical anisotropic body, and liquid crystal display element
KR101622348B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
WO2014003416A1 (en) Polymerizable liquid crystal compound, and liquid crystal composition and optically anisotropic body comprising same
KR101657677B1 (en) Polymerizable liquid crystal compounds, polymerizable liquid crystal composition, optically anisotropic body, and optical element for display device
JPWO2008026482A1 (en) Unsaturated fatty acid ester, polymerizable liquid crystal composition, optically anisotropic material, and optical element using the same
KR101675151B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
KR101682591B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
US9158053B2 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
JP4088863B2 (en) Fumaric acid diester and its liquid crystalline polymer
KR101502487B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
KR101674608B1 (en) Composition for manufacturing optical elements with negative optical dispersion and optically anisotropic body manufactured therefrom
KR101659073B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
KR101659072B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
KR101659071B1 (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
WO2013187668A1 (en) Polymerizable liquid crystal compound, liquid crystal composition containing same, and optical anisotropic body
KR102732180B1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element containing a polymer having a portion having an isocyanate group and/or a blocked isocyanate group and a portion having photoreactivity and a crosslinking agent
US20180282625A1 (en) Polymer, polymer solution, liquid crystal alignment layer, optically anisotropic body, and liquid crystal display element

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13808654

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14355898

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2015520011

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 13808654

Country of ref document: EP

Kind code of ref document: A1